Show simple item record

dc.rights.licenseAtribución-NoComercial-SinDerivadas 4.0 Internacional
dc.contributor.advisorHernández Álvarez, Mario Esteban
dc.contributor.authorParra Salas, Luis Edgar
dc.date.accessioned2021-09-14T19:02:06Z
dc.date.available2021-09-14T19:02:06Z
dc.date.issued2021-09-14
dc.identifier.urihttps://repositorio.unal.edu.co/handle/unal/80190
dc.descriptionIlustraciones y tablas
dc.description.abstractThis research aims to contribute to the construction of an alternative interpretative theoretical framework to the classical liberal hegemonic vision of inequity in access to health technologies, particularly insulin, from the perspective of critical political economy, based on the cognitive capitalism approach. It begins by exploring inequity in access to insulin in Colombia. Then, it analyzes the production, distribution, consumption and capitalist accumulation of insulin during the stage of industrial capitalism, from its discovery to its mass production, to enter later, in the same analysis in the stage of cognitive capitalism, addressing the transition from the pharmacochemical to the biotechnological paradigm, to approach the understanding of the dynamics of knowledge enclosure through the strengthening of intellectual property, and acts of resistance, including biohacking, which understand knowledge as a common good. The emergence of biotechnology and biotechnological drugs, including insulin, is the result of the profound transformations of the contemporary capitalist accumulation regime in the last five decades, where knowledge, the expansion of capitalism in the field of life, intellectual property, and technological change have played a fundamental role in the production of these new health technologies, but at the same time have generated profound inequalities in their access. The results presented here are not a point of arrival but rather a starting point to continue exploring other facets of the proposed problem.
dc.description.abstractEsta investigación pretende aportar a la construcción de un marco teórico interpretativo alterno a la visión clásica hegemónica liberal de la inequidad en el acceso a las tecnologías en salud, en particular de la insulina, desde la perspectiva de la economía política crítica, sustentado en el enfoque del capitalismo cognitivo. Inicia explorando la inequidad en el acceso a la insulina en Colombia. Luego, analiza la producción, distribución, consumo y acumulación capitalista de la insulina durante la etapa del capitalismo industrial, desde su descubrimiento hasta su producción en masa, para adentrarse posteriormente, en igual análisis en la etapa del capitalismo cognitivo, abordando la transición del paradigma farmacoquímico al biotecnológico, para aproximarse a la comprensión de las dinámicas del cercamiento del conocimiento mediante el fortalecimiento de la propiedad intelectual, y a los actos de resistencia, entre ellos el biohacking, que entienden al conocimiento como un bien común. La emergencia de la biotecnología y de los medicamentos biotecnológicos entre ellos la insulina es el resultado de las profundas transformaciones del régimen de acumulación capitalista contemporáneo en las últimas cinco décadas, en donde el conocimiento, la expansión del capitalismo en el ámbito de la vida, la propiedad intelectual, y el cambio tecnológico han jugado un papel fundamental en la producción de estas nuevas tecnologías en salud, pero a la vez han generado profundas inequidades en su acceso. Los resultados aquí presentados no son un punto de llegada sino mejor, son un punto de partida para continuar explorando otras facetas del problema propuesto. (Texto tomado de la fuente).
dc.description.sponsorshipColciencias (Minciencias)
dc.format.extentxx, 376 páginas
dc.format.mimetypeapplication/pdf
dc.language.isospa
dc.publisherUniversidad Nacional de Colombia
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.ddc610 - Medicina y salud
dc.titleDeterminación social de la inequidad en el acceso a los medicamentos biotecnológicos en el capitalismo cognitivo: el caso de la insulina recombinante en Colombia
dc.typeTrabajo de grado - Doctorado
dc.type.driverinfo:eu-repo/semantics/doctoralThesis
dc.type.versioninfo:eu-repo/semantics/acceptedVersion
dc.publisher.programBogotá - Medicina - Doctorado en Salud Pública
dc.contributor.researchgroupEstudios sociohistóricos de la salud y la protección social
dc.coverage.countryColombia
dc.description.degreelevelDoctorado
dc.description.degreenameDoctor en Salud Pública
dc.description.funderColciencias (Minciencias) Convocatoria 617 de 2013
dc.description.methodsHermenéutico interpretativo.
dc.description.researchareaEquidad y Determinación Social en Salud
dc.identifier.instnameUniversidad Nacional de Colombia
dc.identifier.reponameRepositorio Institucional Universidad Nacional de Colombia
dc.identifier.repourlhttps://repositorio.unal.edu.co/
dc.publisher.departmentDoctorado Interfacultades en Salud Pública
dc.publisher.facultyFacultad de Medicina
dc.publisher.placeBogotá, Colombia
dc.publisher.branchUniversidad Nacional de Colombia - Sede Bogotá
dc.relation.indexedBireme
dc.relation.referencesAbbondanzieri, C. (2020). Actores privados y salud global en el sistema de cooperación internacional: un vínculo reforzado en el marco de la pandemia de COVID-19 [Private actors and global health in the international cooperation system: a strengthened link in the COVID-19 pandemic context] [Journal Article]. Perspectivas Revista de Ciencias Sociales, 5(10), 494 - 519. https://doi.org/10.35305/prcs.v0i10.376
dc.relation.referencesAcuña, C., Marina, N., Mendoza, A., Emmerick, I. C. M., Luiza, V. L., & Azeredo, T. B. (2014). Determinantes sociales de la exclusión a los servicios de salud y a medicamentos en tres países de América Central [Social determinants of exclusion from health services and medicines in three central american countries] [Journal Article]. Revista Panamericana de Salud Pública, 35(2), 128-135. http://www.scielosp.org/pdf/rpsp/v35n2/a07v35n2.pdf
dc.relation.referencesAcuña, L., Sánchez, P., Soler, L. A., & Alvis, L. F. (2016). Enfermedad renal en Colombia: prioridad para la gestión de riesgo [Kidney disease in Colombia: Priority for risk management] [Journal Article]. Revista Panamericana de Salud Publica, 40(1), 16-22. https://www.scielosp.org/pdf/rpsp/2016.v40n1/16-22/es
dc.relation.referencesAinsberg, A. (2011). Breakthrough – the story of Elizabeth Hughes and the making of a medical miracle. Diabetes Voice, 56(2), 45-46. https://idf.org/component/attachments/attachments.html?id=289&task=download
dc.relation.referencesAlbritton, R. (2010). Between obesity and hunger: The Capitalist Food Industry. In L. Panitch & C. Leys (Eds.), Socialist Register 2010 "Morbid Symptoms-Health Under Capitalism" (Vol. 46, pp. 184-197). The Merlin Press Ltd. https://socialistregister.com/index.php/srv/article/view/6770/3923
dc.relation.referencesAlcalá, B., & Zozaya, N. (2018). Hacia un abordaje de los medicamentos innovadores basado en el valor [Journal Article]. Revista española de Economía de la Salud, 13(1), 92-103. http://weber.org.es/wp-content/uploads/2018/04/ARticulo_Analisis01ValorMedicamentosIn.pdf
dc.relation.referencesAlfonso Orta, I., & Sánchez de la Cruz, E. R. (2008). Ciencia y politica: El acceso a los medicamentos en el mundo de hoy [Journal Article]. Revista Habanera de Ciencias Médicas, 7(4), 1-18. http://scielo.sld.cu/pdf/rhcm/v7n4/rhcm12408.pdf
dc.relation.referencesAllan, F. N. (1972). Diabetes before and after insulin [Journal Article]. Medical History, 16(3), 266-273. https://doi.org/10.1017/S0025727300017750
dc.relation.referencesÁlvarez, B. T. (2017). De materia medica: Un clásico de la fitoterapia mil veces versionado. Revista Ciencia y Cultura, 5(2). https://www.revistac2.com/de-materia-medica/
dc.relation.referencesÁlvarez Torices, J. C., Pérez Gutiérrez, C., & García Iglesias, M. J. (2018). Aquellas viejas insulinas ¿Qué fue de ellas? [Journal Article]. Diabetes Práctica, 09(01), 2-9. http://www.diabetespractica.com/files/1523003898.01_editorial_dp-9-1.pdf
dc.relation.referencesAmarakoon, I. I., Hamilton, C. L., Mitchell, S. A., Tennant, P. F., & Roye, M. E. (2017). Biotechnology. In S. Badal McCreath & R. Delgoda (Eds.), Pharmacognosy: Fundamentals, Applications and Strategies (1 ed., pp. 549-563). Elsevier Inc. https://doi.org/10.1016/B978-0-12-802104-0.00028-7
dc.relation.referencesAngell, M. (2006). La verdad acerca de la industria farmacéutica: Cómo nos engaña y qué hacer al respecto [Truth about the drug companies. How they deceive us and what to do about it] (L. Freire, Trans.) [Book]. Grupo Editorial Norma.
dc.relation.referencesArias-Valencia, S. (2017). Epidemiología, equidad en salud y justicia social [Epidemiology, health equity and social justice / Epidemiologia, equidade em saúde e justiça social] [Journal Article]. Revista Facultad Nacional de Salud Pública, 35(2), 186-196. https://doi.org/10.17533/udea.rfnsp.v35n2a03
dc.relation.referencesArrighi, G. (2007). La globalización, la soberanía estatal y la interminable acumulación del capital. In Desarrollo: Crónica de un desafío permanente (pp. 183-216).
dc.relation.referencesBacevic, J., & Muellerleile, C. (2018). The moral economy of open access [Journal Article]. European Journal of Social Theory, 21(2), 169-188. https://doi.org/10.1177/1368431017717368
dc.relation.referencesBall, C. (2006). The early development of intravenous apparatus [Journal Article]. Anaesthesia & Intensive Care, 34(Suppl. 1), 22-26. https://doi.org/10.1177/0310057X0603401S02
dc.relation.referencesBanks, M. (2016). What Sci-Hub Is and Why It Matters. American Libraries, 47(6), 46-48. https://americanlibrariesmagazine.org/2016/05/31/why-sci-hub-matters/
dc.relation.referencesBanting, F. G., Best, C. H., & Macleod, J. J. R. (1922). The Internal secretion of the pancreas. American Journal of Physiology(59). https://iiif.library.utoronto.ca/image/v2/insulin:T10131_0001/full/full/0/default.jpg
dc.relation.referencesBarbosa de Oliveira, M. (2009). Sobre el carácter cuantitativo de la evaluación neoliberal de la Universidad (T. e. I. P. Observatorio de Nuevas Prácticas y Alternativas Tecnológicas (ONPAT) y Programa Consejo de la Demanda de Actores Sociales (PROCODAS) del Ministerio de Ciencia, Trans.). In F. Tula Molina & G. Giuliano (Eds.), Iº Encuentro Internacional de Culturas Científicas y Alternativas Tecnológicas (pp. 87-118). Ministerio de Ciencia, Tecnología e Innovación Productiva de la Nación,. https://www.argentina.gob.ar/sites/default/files/culturas-cientificas-y-alternativas-tecnologicas-1.pdf#page=78
dc.relation.referencesBarbosa de Oliveira, M. (2013). On the Commodification of Science: The Programmatic Dimension [Journal Article]. Science & Education, 22(10), 2463-2483. https://doi.org/10.1007/s11191-012-9455-7
dc.relation.referencesBarbosa de Oliveira, M. (2019a). Empresariamento da Universidade: consequências nefastas do produtivismo [Journal Article]. Revista Adusp(63), 59-72. https://www.adusp.org.br/files/revistas/63/09.pdf
dc.relation.referencesBarbosa de Oliveira, M. (2019b). Neoliberalismo, patentes e direitos autorais: estudo introdutório [Journal Article]. http://paje.fe.usp.br/~mbarbosa/npda.pdf
dc.relation.referencesBarbosa de Oliveira, M. (2020). Neoliberalismo e ciência: O caráter nefasto da mercantilização [Journal Article]. Revista Electrónica O Comuneiro(30), 0-0. http://www.ocomuneiro.com/nr30_07_MarcosBarbosadeOliveira.html
dc.relation.referencesBarkan, I. D. (1985). Industry Invites Regulation: The Passage of the Pure Food and Drug Act of 1906 [Journal Article]. American Journal of Public Health, 75(1), 18-26. https://doi.org/10.2105/AJPH.75.1.18
dc.relation.referencesBarnard, K. D., Ziegler, R., Klonoff, D. C., Braune, K., Petersen, B., Rendschmidt, T., Finan, D., Kowalski, A., & Heinemann, L. (2018). Open Source Closed-Loop Insulin Delivery Systems: A Clash of Cultures or Merging of Diverse Approaches? [Journal Article]. Journal Of Diabetes Science And Technology, 12(6), 1223-1226. https://doi.org/10.1177/1932296818792577
dc.relation.referencesBarnett, A. H. (2011). Diabetes-science, serendipity and common sense [Journal Article]. Diabetic Medicine, 28(11), 1289-1299. https://doi.org/10.1111/j.1464-5491.2011.03396.x
dc.relation.referencesBarron, M. (1920). Relation of the Islets of Langerhans to diabetes with special reference to cases of pancreatic lithiasis. Surgery, Gynecology and Obstetrics(31), 437-448. https://insulin.library.utoronto.ca/islandora/object/insulin%3AT10001
dc.relation.referencesBasu, S., Yudkin, J. S., Kehlenbrink, S., Davies, J. I., Wild, S. H., Lipska, K. J., Sussman, J. B., & Beran, D. (2019). Estimation of global insulin use for type 2 diabetes, 2018–30: a microsimulation analysis [Journal Article]. The Lancet Diabetes & Endocrinology, 7(1), 25-33. https://doi.org/10.1016/S2213-8587(18)30303-6
dc.relation.referencesBayer. (2019). Blog de Bayer: ¿Qué son las formas galénicas? Retrieved 10/11/2019 from https://blog.bayer.es/que-son-las-formas-galenicas/
dc.relation.referencesBazargani, Y. T., Ewen, M., de Boer, A., Leufkens, H. G. M., & Mantel-Teeuwisse, A. K. (2014). Essential Medicines Are More Available than Other Medicines around the Globe [Journal Article]. Plos One, 9(2), e87576. https://doi.org/10.1371/journal.pone.0087576
dc.relation.referencesBBC Mundo. (2017). Por qué algunos medicamentos continúan siendo caros pese a tener la patente caducada. BBC Mundo. Retrieved 08 enero 2020 from https://www.bbc.com/mundo/noticias-40704845
dc.relation.referencesBeall, R. F., Nickerson, J. W., Kaplan, W. A., & Attaran, A. (2016). Is Patent “Evergreening” Restricting Access to Medicine/Device Combination Products? [Journal Article]. Plos One, 11(2), 1-13. https://doi.org/10.1371/journal.pone.0148939
dc.relation.referencesBeran, D. (2011). Improving access to insulin: what can be done? [Journal Article]. Diabetes Manage, 1(1), 67-76. https://doi.org/10.2217/dmt.10.5
dc.relation.referencesBeran, D., Ewen, M., & Laing, R. (2016). Constraints and challenges in access to insulin: a global perspective [Journal Article]. The Lancet Diabetes & Endocrinology, 4(3), 275-285. https://doi.org/10.1016/S2213-8587(15)00521-5
dc.relation.referencesBeran, D., Ewen, M., Lipska, K., Hirsch, I. B., & Yudkin, J. S. (2018). Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment [Journal Article]. Current Diabetes Reports, 18(48), 1-10. https://doi.org/10.1007/s11892-018-1019-z
dc.relation.referencesBeran, D., Hirsch, I. B., & Yudkin, J. S. (2018). Why Are We Failing to Address the Issue of Access to Insulin? A National and Global Perspective [Journal Article]. Diabetes Care, 41(6), 1125-1131. https://doi.org/10.2337/dc17-2123
dc.relation.referencesBeran, D., Laing, R. O., Kaplan, W., Knox, R., Sharma, A., Wirtz, V. J., Frye, J., & Ewen, M. (2019). A perspective on global access to insulin: a descriptive study of the market, trade flows and prices [Journal Article]. Diabetic Medicine, 36(6), 726-733. https://doi.org/10.1111/dme.13947
dc.relation.referencesBeran, D., & Yudkin, J. S. (2013). The double scandal of insulin [Journal Article - Editorial]. Journal of the Royal College of Physicians of Edinburgh, 43(3), 194-196. https://doi.org/10.4997/JRCPE.2013.301
dc.relation.referencesBerg, P., & Singer, M. (1995). The Recombinant DNA Controversy: Twenty Years Later [Journal Article]. Bio/Technology, 13(10), 1132-1134. https://doi.org/10.1038/nbt1095-1132
dc.relation.referencesBernal-Acevedo, O., & Forero-Camacho, J. C. (2011). Sistemas de información en el sector salud en Colombia [Information systems in health sector in Colombia / Sistemas de informação no setor saúde na Colômbia] [Journal Article]. Gerencia y Políticas de Salud, 10(21), 85-100. https://doi.org/10.11144/Javeriana.rgsp10-21.siss
dc.relation.referencesBhatia, S. (2018). History, scope and development of biotechnology. In Introduction to Pharmaceutical Biotechnology: Basic techniques and concepts (Vol. 1, pp. 1-61). IOP Publishing. https://doi.org/10.1088/978-0-7503-1299-8ch1
dc.relation.referencesBirn, A.-E., & Richter, J. (2016). El filantrocapitalismo de los EUA y la agenda mundial de salud: las Fundaciones Rockefeller y Gates, pasado y presente [Journal Article]. Medicina Social, 11(3), 135-152. https://www.medicinasocial.info/index.php/medicinasocial/article/view/971
dc.relation.referencesBlevins, S. M., & Bronze, M. S. (2010). Robert Koch and the ‘golden age’ of bacteriology [Journal Article]. International Journal of Infectious Diseases, 14(9), e744-e751. https://doi.org/10.1016/j.ijid.2009.12.003
dc.relation.referencesBlicklé, J. F., & Brogard, J. M. (2013). Les débuts de l’insulinothérapie en France [The beginning of insulin therapy in France] [Journal Article]. Médecine des Maladies Métaboliques, 7(2), 185-190. https://doi.org/10.1016/S1957-2557(13)70523-6
dc.relation.referencesBliss, M. (1986). Who Discovered Insulin? [Journal Article]. Physiology, 1(1), 31-36. https://doi.org/10.1152/physiologyonline.1986.1.1.31
dc.relation.referencesBliss, M. (2005). Resurrections in Toronto: The Emergence of Insulin [Journal Article]. Hormone Research, 64(Suppl. 2), 98-102. https://doi.org/10.1159/000087765
dc.relation.referencesBliss, M. (2017). The Discovery of Insulin (25th anniversary ed.) [Book]. University of Toronto Press, Scholarly Publishing Division.
dc.relation.referencesBOAI. (2002). Iniciativa de Budapest para el Acceso Abierto. Retrieved 08 de junio de 2020 from https://www.budapestopenaccessinitiative.org/translations/spanish-translation
dc.relation.referencesBobulescu, R., & Soulas, C. (2006). Innovation and firm size in the pharmaceutical industry [Journal Article]. International Journal of Business Environment, 1(2), 253-264. https://doi.org/10.1504/IJBE.2006.010687
dc.relation.referencesBohannon, J. (2016). Who’s Downloading Pirated Papers? Everyone [Journal Article]. Science, 352(6285), 508-512. https://doi.org/10.1126/science.352.6285.508
dc.relation.referencesBohannon, J., & Elbakyan, A. (2017). Data from: Who's downloading pirated papers? Everyone [Web page]. Dryad - Dataset. https://doi.org/10.5061/dryad.q447c
dc.relation.referencesBok, D. (2003). Universities in the marketplace: The commercialization of higher education [Book]. Princeton University Press.
dc.relation.referencesBosch, F., & Rosich, L. (2008). The Contributions of Paul Ehrlich to Pharmacology: A Tribute on the Occasion of the Centenary of His Nobel Prize [Journal Article]. Pharmacology, 82(3), 171-179. https://doi.org/10.1159/000149583
dc.relation.referencesBoyle, J. (2003). The Second Enclosure Movement and the Construction of the Public Domain [Journal Article]. Law and Contemporary Problems, 66(1-2), 33-74. https://scholarship.law.duke.edu/cgi/viewcontent.cgi?article=1273&context=lcp
dc.relation.referencesBreilh, J. (2013). La determinación social de la salud como herramienta de transformación hacia una nueva salud pública (salud colectiva) [The social health determination as a tool of transformation towards a new public health (community health)] [Journal Article]. Revista Facultad Nacional de Salud Pública, 31(Supl. 1), 13-27. https://revistas.udea.edu.co/index.php/fnsp/article/view/16637/14425
dc.relation.referencesBuchholz, K., & Collins, J. (2010). Concepts in Biotechnology : History, Science and Business [Book]. Wiley-VCH.
dc.relation.referencesBuranyi, S. (2017). Is the staggeringly profitable business of scientific publishing bad for science? The Guardian. https://www.theguardian.com/science/2017/jun/27/profitable-business-scientific-publishing-bad-for-science
dc.relation.referencesBurdeau, I. (2015). The Last Great Enclosure: The Crisis of the General Intellect [Journal Article]. WorkingUSA: The Journal of Labor and Society, 18(4), 649–663. https://doi.org/10.1111/wusa.12217
dc.relation.referencesBurlage, R., & Anderson, M. (2018). The Medical-Industrial Complex in the Age of Financialization. In H. Waitzkin (Ed.), Health Care Under the Knife : Moving Beyond Capitalism for Our Health (1 ed., pp. 69-82). Monthly Review Press.
dc.relation.referencesBurningham, G. (2019). The Price of Insulin Has Soared. These Biohackers Have a Plan to Fix It. TIME Magazine, 194(18/19), 74-79. https://time.com/5709241/open-insulin-project/
dc.relation.referencesBurrill, G. S. (2014). Chapter 3 - The Biotechnology Industry: An Engine of Innovation. In C. Shimasaki (Ed.), Biotechnology Entrepreneurship: Starting, Managing, and Leading Biotech Companies (pp. 21-44). Elsevier Inc. https://doi.org/10.1016/B978-0-12-404730-3.00003-8
dc.relation.referencesBush, V. (2020). Science - The Endless Frontier (75th Anniversary Edition) [Report]. https://www.nsf.gov/about/history/EndlessFrontier_w.pdf
dc.relation.referencesCamargo Jr., K. R. d. (2018). On health needs: the concept labyrinth [Sobre as necessidades de saúde: um labirinto conceitual / Sobre las necesidades en salud: un laberinto conceptual] [Journal Article]. Cadernos De Saude Publica, 34(6), e00113717-e00113717. https://doi.org/10.1590/0102-311X00113717
dc.relation.referencesCAMe BIO. (2016). Biotecnológicos. Los medicamentos del futuro [Report]. http://www.caeme.org.ar/notasimg/phpEiLiEX3882.pdf
dc.relation.referencesCampbell-Araujo, Ó. A., & Figueroa-Duarte, A. S. (2003). La Doble Hélice (ADN), 50 años después [Journal Article]. Boletin Clinico Hospital Infantil del Estado de Sonora, 20(2), 128-134. https://www.imbiomed.com.mx/articulo.php?id=17597
dc.relation.referencesCano Ramírez, O. E. (2017). Capitaloceno y adaptación elitista [Journal Article]. Ecología Política(53), 8-11. https://dialnet.unirioja.es/servlet/articulo?codigo=6063824
dc.relation.referencesCárcamo Vásquez, H. (2005). Hermenéutica y Análisis Cualitativo [Journal Article]. Cinta Moebio(23), 204-216. http://www.redalyc.org/articulo.oa?id=10102306
dc.relation.referencesCassier, M. (2003). L'expansion du capitalisme dans le domaine du vivant : droits de propriété intellectuelle et marchés de la science, de la matière biologique et de la santé [Journal Article]. Actuel Marx(34), 63-80. https://www.cairn.info/revue-internationale-des-sciences-sociales-2002-1-page-95.htm
dc.relation.referencesCassier, M., & Sinding, C. (2008). ‘Patenting in the public interest:’ administration of insulin patents by the University of Toronto [Journal Article]. History and Technology, 24(2), 153-171. https://doi.org/10.1080/07341510701810948
dc.relation.referencesCastro Martínez, P. (1994). Los años de Mulroney: el fin de una era apacible [Journal Article]. Revista Comercio Exterior, 44(1), 11-18. http://revistas.bancomext.gob.mx/rce/magazines/355/3/RCE3.pdf
dc.relation.referencesCefalu, W. T., Dawes, D. E., Gavlak, G., Goldman, D., Herman, W. H., Van Nuys, K., Powers, A. C., Taylor, S. I., & Yatvin, A. L. (2018). Insulin Access and Affordability Working Group: Conclusions and Recommendations [Journal Article]. Diabetes Care, 41(6), 1299-1311. https://doi.org/10.2337/dci18-0019
dc.relation.referencesChan, M. (2017). Obesity and Diabetes: The Slow-Motion Disaster [Journal Article]. The Milbank Quarterly, 95(1), 11-14. https://doi.org/10.1111/1468-0009.12238
dc.relation.referencesChazkel, A. (2011). Confronting the Enclosure of the Cultural Commons [Journal Article]. Radical History Review(109), 137-152. https://doi.org/10.1215/01636545-2010-020
dc.relation.referencesChobot, A., Górowska-Kowolik, K., Sokołowska, M., & Jarosz-Chobot, P. (2018). Obesity and diabetes—Not only a simple link between two epidemics [Journal Article]. Diabetes/Metabolism Research And Reviews, 34(7), e3042-e3051. https://doi.org/10.1002/dmrr.3042
dc.relation.referencesClowes, A. W. (2016). The Doc and the Duchess : The Life and Legacy of George H. A. Clowes [Book]. Indiana University Press. http://ezproxy.unal.edu.co/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=nlebk&AN=1155242&lang=es&site=eds-live
dc.relation.referencesCollier, R. (2013). Drug patents: the evergreening problem [Journal Article]. Canadian Medical Association Journal, 185(9), E385-E386. https://doi.org/10.1503/cmaj.109-4466
dc.relation.referencesLey 1438, (2011). https://colaboracion.dnp.gov.co/CDT/Normatividad/ley1438de2011.pdf
dc.relation.referencesCONICYT. (2015). Biofármacos: Biotecnología al servicio de la salud. Retrieved 01/05/2015 from http://www.explora.cl/descubre/articulos-de-ciencia/tecnologia-articulos/biotecnologia-articulos/1704-biofarmacos-biotecnologia-al-servicio-de-la-salud
dc.relation.referencesConrad, P., & Leiter, V. (2004). Medicalization, Markets and Consumers [Journal Article]. Journal of Health and Social Behavior, 45(Extra Issue), 158-176. https://www-jstor-org.ezproxy.javeriana.edu.co/stable/3653830
dc.relation.referencesConrad, P., & Leiter, V. (2008). From Lydia Pinkham to Queen Levitra: direct-to-consumer advertising and medicalisation [Report]. Sociology of Health & Illness, 30(6), 825–838. https://doi.org/10.1111/j.1467-9566.2008.01092.x
dc.relation.referencesCooper, M. (2007). Life, autopoiesis, debt: Inventing the Bioeconomy [Journal Article]. Distinktion: Scandinavian Journal of Social Theory, 8(1), 25-43. https://doi.org/10.1080/1600910X.2007.9672937
dc.relation.referencesCooper, M. (2008). Life As Surplus : Biotechnology and Capitalism in the Neoliberal Era [Book]. University of Washington Press. http://www.jstor.org/stable/j.ctvcwnt6d
dc.relation.referencesCorsani, A., Dieuaide, P., Lazzarato, M., Monnier, J. M., Moulier-Boutang, Y., Paulré, B., & Vercellone, C. (2001). Le capitalisme cognitif comme sortie de la crise du capitalisme industriel : Un programme de recherche [Conference paper]. Forum de la Régulation, Paris. https://n9.cl/dm3u
dc.relation.referencesCostantino, H. R., Liauw, S., Mitragotri, S., Langer, R., Klibanov, A. M., & Sluzky, V. (1997). The Pharmaceutical Development of Insulin: Historical Perspectives and Future Directions. In Therapeutic Protein and Peptide Formulation and Delivery (Vol. 675, pp. 29-66). American Chemical Society. https://doi.org/10.1021/bk-1997-0675.ch002
dc.relation.referencesCox, C. (2011). Elizabeth Evans Hughes—surviving starvation therapy for diabetes [Journal Article]. The Lancet, 377(9773), 1232-1233. https://doi.org/10.1016/S0140-6736(11)60490-X
dc.relation.referencesCrawford, J. (2021). ¿Tiene Bill Gates demasiada influencia en la OMS? SWI swissinfo.ch. Retrieved 06 de junio de 2021 from https://www.swissinfo.ch/spa/-tiene-bill-gates-demasiada-influencia-en-la-oms-/46588758#number_of_comments
dc.relation.referencesCuenta de Alto Costo. (2018). Día mundial de la diabetes Nov. 14 de 2018 [Report]. Boletín de información técnica especializada, 4(17), 1-6. http://www.med-informatica.net/STAR/Diabetes2/CAC_Boletin_Dia_Mundial_de_la_Diabetes14nov18.pdf
dc.relation.referencesCuenta de Alto Costo. (2019). Situación de la enfermedad renal crónica, la hipertensión arterial y la diabetes mellitus en Colombia 2018 [Report]. https://cuentadealtocosto.org/site/wp-content/uploads/2020/03/libro-erc-2018.pdf
dc.relation.referencesCuenta de Alto Costo. (2020a). ¿Quiénes somos? Cuenta de Alto Costo. Retrieved 18 de agosto de 2020 from https://cuentadealtocosto.org/site/quienes-somos/
dc.relation.referencesCuenta de Alto Costo. (2020b). Situación de la enfermedad renal crónica, la hipertensión arterial y la diabetes mellitus en Colombia 2019 [Report]. https://cuentadealtocosto.org/site/wp-content/uploads/2020/06/CAC.Co_2020_06_24_Libro_Sit_ERC_2019V7.pdf
dc.relation.referencesCuenta de Alto Costo. (2021). ¿Qué es ERC? Cuenta de Alto Costo. Retrieved 06 de junio de 2021 from https://cuentadealtocosto.org/site/erc/
dc.relation.referencesD’Antonio Maceiras, S. (2018). El círculo vicioso de las revistas científicas y la progresiva irrelevancia de la ciencia pública [The vicious circle of scientific journals and the progressive irrelevance of public science] [Journal Article]. Politica y Sociedad, 55(2), 467-490. https://doi.org/10.5209/POSO.57222
dc.relation.referencesDa Silveira, S. A. (2013). Aaron Swartz and the battles for freedom of knowledge [Journal Article]. SUR International Journal on Human Rights, 10(18), 6-15. https://doi.org/10.2139/ssrn.2399578
dc.relation.referencesDahm, R. (2005). Friedrich Miescher and the discovery of DNA [Journal Article]. Developmental Biology, 278(2), 274-288. https://doi.org/10.1016/j.ydbio.2004.11.028
dc.relation.referencesDarat, N., & Tello, A. M. (2016). "Desobediencia intelectual": resistencias a la privatización del conocimiento [Journal Article]. Polis Revista Latinoamericana(43), 313-329. https://doi.org/10.4067/S0718-65682016000100015
dc.relation.referencesDe Angelis, M. (2004). Separating the Doing and the Deed: Capital and the Continuous Character of Enclosures [Journal Article]. Historical Materialism, 12(2), 57–87. https://doi.org/10.1163/1569206041551609
dc.relation.referencesDe Kruif, P. (1995). Microbe Hunters (3 ed.) [Book]. Harcourt Brace Jovanovich.
dc.relation.referencesde Leiva-Hidalgo, A., & de Leiva-Perez, A. (2020). Experiences of First Insulin-Treated Patients (1922-1923) [Academic Article]. American Journal of Therapeutics, 27(1), e13-e23. https://doi.org/10.1097/MJT.0000000000001069
dc.relation.referencesde Leiva, A., Brugués, E., & de Leiva-Pérez, A. (2011). El descubrimiento de la insulina: continúan las controversias después de noventa años [The discovery of insulin: Continued controversies after ninety years] [Journal Article]. Endocrinologia y Nutricion, 58(9), 449-456. https://doi.org/10.1016/j.endonu.2011.10.001
dc.relation.referencesDefensoría del Pueblo. (2020a). La tutela y los derechos a la salud y a la seguridad social 2019 [Report]. https://www.defensoria.gov.co/public/pdf/Estudio-La-Tutela-Derechos-Salud-Seguridad-Social-2019.pdf
dc.relation.referencesDefensoría del Pueblo. (2020b). Más de 620.000 tutelas se instauraron en 2019 para proteger derechos fundamentales. Retrieved 20 de agosto de 2020 from https://www.defensoria.gov.co/es/nube/comunicados/9441/M%C3%A1s-de-620000-tutelas-se-instauraron-en-2019-para-proteger-derechos-fundamentales-derechos-salud-Defensor%C3%ADa-tutelas.htm
dc.relation.referencesDefries, R. D. (1948). The Connaught Medical Research Laboratories 1914-1948 [Journal Article]. Canadian Journal of Public Health / Revue canadienne de santé publique, 39(8), 330-344. https://www-jstor-org.ezproxy.unal.edu.co/stable/41979831
dc.relation.referencesDelgado Cabeza, M. (2010). El sistema agroalimentario globalizado: Imperios alimentarios y degradación social y ecologica [Journal Article]. Revista de Economía Crítica(10), 32-61. http://revistaeconomiacritica.org/sites/default/files/revistas/n10/3.pdf
dc.relation.referencesDemortain, D. (2015). The tools of globalization: ways of regulating and the structure of the international regime for pharmaceuticals [Journal Article]. Review of International Political Economy, 22(6), 1249-1275. https://doi.org/10.1080/09692290.2015.1066695
dc.relation.referencesDIYBIO. (2011). DIYbio Codes. Retrieved 21 de enero de 2020 from https://diybio.org/codes
dc.relation.referencesDNDi. (2015). Drugs for Neglected Diseases initiative. Retrieved 23 de mayo de 2015 from http://www.dndi.org/
dc.relation.referencesDong, A. H. T. (2018). Biohacking: The next scientific revolution? [Journal Article]. Meducator, 1(33), 10-10. https://journals.mcmaster.ca/meducator/article/view/1793/1404
dc.relation.referencesDouglas, D. M. (2016). Doxing: a conceptual analysis [Journal Article]. Ethics and Information Technology, 18(3), 199-210. https://doi.org/10.1007/s10676-016-9406-0
dc.relation.referencesDrahos, P., & Braithwaite, J. (2002). Information Feudalism : Who Owns the Knowledge Economy? [Book]. Earthscan Publications Ltd. https://doi.org/10.4324/9781315092683
dc.relation.referencesDrahos, P., & Braithwaite, J. (2004). Une hégémonie de la connaissance - Les enjeux des débats sur la propriété intellectuelle [Hegemony Based on Knowledge - The Role of Intellectual Property] [article in journal/newspaper]. Actes de la Recherche en Sciences Sociales(151-152), 69-79. https://doi.org/10.3917/arss.151.0068
dc.relation.referencesDuRand, C. (2014). Contradictions of Global Neoliberalism [Article]. Perspectives on Global Development & Technology, 13(1/2), 36-42. https://doi.org/10.1163/15691497-12341287
dc.relation.referencesDutfield, G. (2009). Intellectual property rights and the life science industries: past, present and future [Book]. World Scientific. https://doi.org/10.1142/6917
dc.relation.referencesDutfield, G. (2016). Intellectual Property Rights and the Life Science Industries : A Twentieth Century History [Book]. Routledge. https://doi.org/10.4324/9781315252131
dc.relation.referencesDyer, C. (2006). Conflict in the landscape: the enclosure movement in England, 1220-1349. Landscape History, 28, 21-33. https://doi.org/10.1080/01433768.2006.10594578
dc.relation.referencesDyson, F. (2007). Our biotech future. New York Review of Books, 54(12), 4-8. https://www.nybooks.com/articles/2007/07/19/our-biotech-future/
dc.relation.referencesEdelman, S., Polonsky, W. H., & Parkin, C. G. (2014). Biosimilar insulins are coming: what they are, what you need to know. Current Medical Research And Opinion, 30(11), 2217-2222. https://doi.org/10.1185/03007995.2014.952718
dc.relation.referencesEdyvane, D., & Kulenovic, E. (2017). Disruptive Disobedience [Article]. Journal of Politics, 79(4), 1359-1371. https://doi.org/10.1086/692666
dc.relation.referencesEngelhardt, D. v., Wilson, A., Striker, C., Jaenecke, W., Schadewaldt, H., Ebstein, E., Kalbfleisch, K., Orth, H., Henschen, F., Leopold, E. J., Porkert, M., Müller, R. F. G., Schadewaldt, H., Zimmermann, O. C., Marble, A., Horst, e. a., Dittrich, H.-M. e. a., Ebstein, E., Grmek, M. D., Porep, R., Wolff, G., Houssay, B. A., Joslin, E. P., Fischer, F., Thomsen, V., Leickert, K. H., Wilder, R. M., Pratt, J. H., Martin, E., Drügemöller, P. e. a., Korp, W. e. a., Lawrence, R. D., & Striker, C. (1989). Diabetes Its Medical and Cultural History (D. v. Engelhardt, Ed.). Springer-Verlag. https://doi.org/10.1007/978-3-642-48364-6
dc.relation.referencesEslava-Castañeda, J. C. (2017). Pensando la determinación social del proceso salud-enfermedad [Thinking about the social determination of the health-disease process.] [Article]. Revista de Salud Pública, 19(3), 396-403. https://doi.org/10.15446/rsap.v19n3.68467
dc.relation.referencesEsper, R. C., Córdova, J. R. C., & Córdova, L. D. C. (2008). Nicolae Constantine Paulescu: el descubrimiento de la insulina y el Premio Nobel de 1923 [Nicolae Constantine Paulescu, insulin discovery and the 1923 Nobel Prize] [Article]. Medicina Interna de Mexico, 24(2), 157-164. https://www.medigraphic.com/pdfs/medintmex/mim-2008/mim082i.pdf
dc.relation.referencesEspinoza Lolas, R., Moreno Doña, A., & Gómez-Gonzalvo, F. (2019). El problema de la obesidad en tiempos de capitalismo tardío: de la economía neoliberal a las políticas públicas colaborativas basadas en el buen vivir. Saúde e Sociedade, 28(2), 239-248. https://doi.org/10.1590/S0104-12902019180791
dc.relation.referencesEuropean Federation of Pharmaceutical Industries and Asociation. (2014). The Pharmaceutical Industry in figures - Edition 2014. http://efpia.eu/mediaroom/177/44/The-Pharmaceutical-Industry-in-figures-Edition-2014
dc.relation.referencesEvaluate Ltd. (2017). EvaluatePharma®World Preview 2017, Outlook to 2022 (Annual Pharma Report, Issue. http://www.evaluategroup.com/public/reports/EvaluatePharma-World-Preview-2017.aspx
dc.relation.referencesEvaluate Ltd. (2018). EvaluatePharma®World Preview 2018, Outlook to 2024 (Annual Pharma Report, Issue. http://info.evaluategroup.com/rs/607-YGS-364/images/WP2018.pdf
dc.relation.referencesEvens, R. P., & Kaitin, K. I. (2014). The biotechnology innovation machine: a source of intelligent biopharmaceuticals for the pharma industry--mapping biotechnology's success. Clinical Pharmacology And Therapeutics, 95(5), 528-532. https://doi.org/10.1038/clpt.2014.14
dc.relation.referencesFarías Pelcastre, I., & González Correa, F. (2016). The current system of knowledge dissemination isn’t working and Sci-Hub is merely a symptom of the problem. http://eprints.lse.ac.uk/70381/
dc.relation.referencesFarmamundi. (2011). Dossier Medicamentos esenciales recetas que salvan vidas. http://www.esencialesparalavida.org/wp-content/uploads/2014/09/DOSSIER-OK.pdf
dc.relation.referencesFarmamundi. (2015). Datos. Retrieved 08/09/2015 from http://esencialesparalavida.org/presentacion/datos/
dc.relation.referencesFaust, J. S. (2016). Sci-Hub: A Solution to the Problem of Paywalls, or Merely a Diagnosis of a Broken System? Annals of Emergency Medicine, 68(1), A15-A17. https://doi.org/10.1016/j.annemergmed.2016.05.010
dc.relation.referencesFederación Médica Colombiana. (2014). Los países del sur se unen por el acceso a medicamentos biotecnológicos, incluidos los biocompetidores. Retrieved 14/05/2015 from http://www.federacionmedicacolombiana.com/index.php/publicaciones/prensa/noticias/651-los-paises-del-sur-se-unen-por-el-acceso-a-medicamentos-biotecnologicos-incluidos-los-biocompetidores
dc.relation.referencesFelig, P. (1984). Protamine Insulin: Hagedorn's Pioneering Contribution to Drug Delivery in the Management of Diabetes [Article]. JAMA: The Journal of the American Medical Association, 251(3), 393-396. https://doi.org/10.1001/jama.1984.03340270071031
dc.relation.referencesFerrer Lues, M. (2003). Equidad y justicia en salud: Implicaciones para la bioética [Equity and justice in health implications for bioethics / Equidade e justiça em saúde implicações para a bioética]. Acta Bioethica, 9(1), 113-126. https://doi.org/10.4067/S1726-569X2003000100011
dc.relation.referencesFeudtner, J. C. (2003). Bittersweet : Diabetes, Insulin, and the Transformation of Illness [Book]. The University of North Carolina Press. http://ezproxy.javeriana.edu.co:2048/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=nlebk&AN=103991&lang=es&site=eds-live
dc.relation.referencesFish, K. (2003). Biotechnology and the Society-Nature Relation. Alternate Routes: A Journal of Critical Social Research, 19, 58-78. http://www.alternateroutes.ca/index.php/ar/article/view/20350/16771
dc.relation.referencesFish, K. (2013). Living Factories : Biotechnology and the Unique Nature of Capitalism [Book]. McGill-Queen’s University Press.
dc.relation.referencesFlores, B. (1994). Producción de insulina humana por técnicas de ADN recombinante. Ciencias(34), 61-62. https://www.revistaciencias.unam.mx/images/stories/Articles/34/CNS03408.pdf
dc.relation.referencesForbes. (2012). How Much Money Did Jonas Salk Potentially Forfeit By Not Patenting The Polio Vaccine? Retrieved 9/09/2019 from https://www.forbes.com/sites/quora/2012/08/09/how-much-money-did-jonas-salk-potentially-forfeit-by-not-patenting-the-polio-vaccine/#77f76abe69b8
dc.relation.referencesFoscarini, F. (2019). The Patent Genre: Between Stability and Change [Article]. Archivaria The Journal of the Association of Canadian Archivists(87), 36-67. https://archivaria.ca/index.php/archivaria/article/view/13665/15063
dc.relation.referencesFralick, M., & Kesselheim, A. S. (2019). The U.S. Insulin Crisis - Rationing a Lifesaving Medication Discovered in the 1920s [journal article]. New England Journal of Medicine, 381(19), 17931795. https://doi.org/10.1056/NEJMp1909402
dc.relation.referencesFranco, S. (2013). Entre los negocios y los derechos. Revista Cubana de Salud Pública, 39(2), 268-284. http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-34662013000200008&nrm=iso
dc.relation.referencesFranklin, R. E., & Gosling, R. G. (1953). Molecular Configuration in Sodium Thymonucleate. Nature, 171(4356), 740-741. https://doi.org/10.1038/171740a0
dc.relation.referencesFumagalli, A. (2011). Twenty Theses On Contemporary Capitalism (Cognitive Biocapitalism) [Article]. Angelaki: Journal of the Theoretical Humanities, 16(3), 7-17. https://www.tandfonline.com/doi/full/10.1080/0969725X.2011.626555
dc.relation.referencesFumagalli, A., & Lucarelli, S. (2011). Valorization and Financialization in Cognitive Biocapitalism. Investment Management and Financial Innovations, 8(1), 88-103. https://www.businessperspectives.org/images/pdf/applications/publishing/templates/article/assets/3788/imfi_en_2011_01_Fumagalli.pdf
dc.relation.referencesFundación Dr. Antonio Esteve. (2014). Filantropía en investigación e innovación biosanitaria en Cataluña. http://esteve.org/wp-content/uploads/2018/01/13138.pdf
dc.relation.referencesFundación Salud por Derecho. (2015). Investigación Médica: Houston, tenemos un problema. https://www.youtube.com/watch?v=lD2hCCFVuxw
dc.relation.referencesGalán, I., Pérez-Gómez, B., & Primo-Peña, E. (2015). ¿Quién teme al open access? Un movimiento en crecimiento, oportuno y necesario. Gaceta Sanitaria, 29(2), 139-141. https://doi.org/10.1016/j.gaceta.2014.11.010
dc.relation.referencesGalcerán Huguet, M. (2003). El discurso oficial sobre la Universidad [Official discourse regarding the University] [Article]. Logos Anales del Seminario de Metafísica(36), 11-32. http://revistas.ucm.es/index.php/ASEM/article/view/ASEM0303110011A/16129
dc.relation.referencesGalkina Cleary, E., Beierlein, J. M., Khanuja, N. S., McNamee, L. M., & Ledley, F. D. (2018). Contribution of NIH funding to new drug approvals 2010-2016 [Journal Article]. Proceedings of the National Academy of Sciences of the United States of America, 115(10), 2329-2334. https://doi.org/10.1073/pnas.1715368115
dc.relation.referencesGallegos, J. E., Boyer, C., Pauwels, E., Kaplan, W. A., & Peccoud, J. (2018). The Open Insulin Project: A Case Study for 'Biohacked' Medicines [Article]. Trends in Biotechnology, 36(12), 1211-1218. https://doi.org/10.1016/j.tibtech.2018.07.009
dc.relation.referencesGarcía-Sánchez, J. E., García, E., & Lucila Merino, M. (2010). Cien años de la bala mágica del Dr. Ehrlich (1909–2009) [100 years of Dr. Ehrlich's magic bullet (1909–2009)] [Review Article]. Enfermedades Infecciosas y Microbiologia Clinica, 28(8), 521-533. https://doi.org/10.1016/j.eimc.2009.07.009
dc.relation.referencesGardner, K. E. (2019). 'The Art of Insulin Treatment:' Diabetes, Insulin, and the 1920s [Journal Article]. Journal of Medical Humanities, 40(2), 171-180. https://doi.org/10.1007/s10912-017-9493-x
dc.relation.referencesGates Foundation. (2021). We are a nonprofit fighting poverty, disease, and inequity around the world. Gates Foundation,. Retrieved 07 junio de 2021 from https://www.gatesfoundation.org/
dc.relation.referencesGedye, L. (2017). The battle for free knowledge: The issue regarding free access to academic journals and content is growing increasingly contentious, with founders of sites that enable this facing the might of the law. But should knowledge be exclusive? [Article]. Finweek, 41-41. http://ezproxy.unal.edu.co/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=bth&AN=123206640&lang=es&site=eds-live
dc.relation.referencesGelpi, A., Gilbertson, A., & Tucker, J. D. (2015). Magic bullet: Paul Ehrlich, Salvarsan and the birth of venereology. Sexually transmitted infections, 91, 68-68-69. https://doi.org/10.1136/sextrans-2014-051779
dc.relation.referencesGemio, P., Briegas, D., Gutiérrez, I., & Lorenzo, S. (2015). La innovación y el medicamento (Fundación Gaspar Casal, Ed. 1 ed.). Fundación Gaspar Casal,. http://www.fgcasal.org/publicaciones/CT2_La_Innovacion_y_el_medicamento.pdf
dc.relation.referencesGill, M. (2013). Paying the price for the open society. New Statesman, 142(5141), 13-15. http://search.ebscohost.com/login.aspx?direct=true&db=f5h&AN=84988502&site=eds-live
dc.relation.referencesGiraldo Díaz, R. (2006). Poder y resistencia en Michel Foucault [The Power and Resistance in Michel Foucault]. Tabula Rasa(4), 103-122. http://www.scielo.org.co/pdf/tara/n4/n4a06.pdf
dc.relation.referencesGlobal Forum for Health Research. (2010). Informe Innovando para la salud de todos. Council on Health Research for Development. http://announcementsfiles.cohred.org/gfhr_pub/assoc/gf-forum-2009-report-esp.pdf
dc.relation.referencesGodin, B. (2006). The Knowledge-Based Economy: Conceptual Framework or Buzzword? The Journal of Technology Transfer, 31(1), 17-30. https://doi.org/10.1007/s10961-005-5010-x
dc.relation.referencesGonzález Ulloa Aguirre, P. A. (2010). La pérdida del Estado céntrico. Revista de Relaciones Internacionales de la UNAM(107), 149-168. http://revistas.unam.mx/index.php/rri/article/view/21327/20122
dc.relation.referencesGoodman, J. (2003). Pharmaceutical Industry. In R. Cooter & J. Pickstone (Eds.), Companion to Medicine in the Twentieth Century (1th ed., pp. 141-154). Routledge. https://doi.org/10.4324/9780203826522
dc.relation.referencesGopakumar, K. M. (2018). ODS 3 Reforzar la financiación pública de la OMS. Retrieved 6 de junio de 2021 from https://www.globalpolicywatch.org/esp/?p=559
dc.relation.referencesGreene, J. A., & Riggs, K. R. (2015). Why Is There No Generic Insulin? Historical Origins of a Modern Problem. New England Journal of Medicine, 372(12), 1171-1175. https://doi.org/10.1056/NEJMms1411398
dc.relation.referencesGreshake, B. (2017). Looking into Pandora's Box: The Content of Sci-Hub and its Usage. F1000Research, 6, 541. https://doi.org/10.12688/f1000research.11366.1
dc.relation.referencesGutiérrez, J. M., Burnouf, T., Harrison, R. A., Calvete, J. J., Brown, N., Jensen, S. D., Warrell, D. A., Williams, D. J., & Global Snakebite, I. (2015). A Call for Incorporating Social Research in the Global Struggle against Snakebite. PLoS Negl Trop Dis, 9(9), e0003960. https://doi.org/10.1371/journal.pntd.0003960
dc.relation.referencesHageg, Y. (2013). El rol del conocimiento en el proceso de valorización del capital. Facultad de Ciencias Sociales, Universidad de Buenos Aires. http://cdsa.aacademica.org/000-038/707.pdf
dc.relation.referencesHalliburton, M. (2017). India and the Patent Wars : Pharmaceuticals in the New Intellectual Property Regime [Book]. Cornell University Press. https://www-jstor-org.ezproxy.unal.edu.co/stable/10.7591/j.ctt1w1vkb4
dc.relation.referencesHamdouch, A. I., & Depret, M. H. (2001). La nouvelle économie industrielle de la pharmacie : structures industrielles, dynamiques d'innovation et stratégies commerciales [Book]. Elsevier. http://ezproxy.unal.edu.co/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=edszbw&AN=EDSZBW334450055&lang=es&site=eds-live
dc.relation.referencesHart-Landsberg, M. (2013). Capitalist Globalization : Consequences, Resistance, and Alternatives (M. R. Press, Ed.) https://monthlyreview.org/product/capitalist_globalization/
dc.relation.referencesHarvey, D. (2004). El nuevo imperialismo (J. M. Madariaga, Trans.) [Non-fiction]. Ediciones Akal. http://search.ebscohost.com/login.aspx?direct=true&db=cat01040a&AN=pujbc.767385&lang=es&site=eds-live
dc.relation.referencesHarvey, D. (2005). A brief history of neoliberalism [Bibliographies / Non-fiction]. Oxford University Press. http://ezproxy.unal.edu.co/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=edshlc&AN=edshlc.009771408-9&lang=es&site=eds-live
dc.relation.referencesHarvey, D. (2007). Breve historia del neoliberalismo (A. Varela Mateos, Trans.) [Non-fiction]. Akal. http://ezproxy.unal.edu.co/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=cat02704a&AN=unc.000644005&lang=es&site=eds-live
dc.relation.referencesHay, M., Thomas, D. W., Craighead, J. L., Economides, C., & Rosenthal, J. (2014). Clinical development success rates for investigational drugs [Report]. Nature Biotechnology, 32(1), 40-51. https://doi.org/10.1038/nbt.2786
dc.relation.referencesHeede, R. (2014). Tracing anthropogenic carbon dioxide and methane emissions to fossil fuel and cement producers, 1854–2010. Climatic Change, 122(1), 229-241. https://doi.org/10.1007/s10584-013-0986-y
dc.relation.referencesHeller, S., Kozlovski, P., & Kurtzhals, P. (2007). Insulin's 85th anniversary-An enduring medical miracle [Review]. Diabetes Research And Clinical Practice, 78(2), 149-158. https://doi.org/10.1016/j.diabres.2007.04.001
dc.relation.referencesHerkert, D., Vijayakumar, P., Luo, J., Schwartz, J. I., Rabin, T. L., DeFilippo, E., & Lipska, K. J. (2019). Cost-Related Insulin Underuse Among Patients With Diabetes. JAMA Internal Medicine, 179(1), 112-114. https://doi.org/10.1001/jamainternmed.2018.5008
dc.relation.referencesHernández-Álvarez, M. (2008a). Desigualdad, inequidad e injusticia en el debate actual en salud: posiciones e implicaciones. Taller Latinoamericano de Determinantes Sociales de la Salud, México D.F., México.
dc.relation.referencesHernández-Álvarez, M. (2008b). El Concepto de Equidad y el Debate sobre lo Justo en Salud [The concept of equity and the debate about fairness in health]. Revista de Salud Pública, 10, 72-82. http://www.scielo.org.co/pdf/rsap/v10s1/v10s1a07.pdf
dc.relation.referencesHernández-Álvarez, M. (2011). Desigualdad, inequidad e injusticia en el debate actual en salud: posiciones e implicaciones. In C. Eibenschutz Hartman, S. Tamez González, & R. González Guzmán (Eds.), ¿Determinación Social o Determinantes Sociales de la Salud?: Memoria del Taller Latinoamericano sobre Determinantes Sociales de la Salud (1 ed., pp. 169-192). Universidad Autónoma Metropolitana. http://www.saludcapital.gov.co/Artculos%20Observatorio/Desigualdad,%20inequidad%20e%20injusticia_Mario_Hern%C3%A1ndez.pdf
dc.relation.referencesHernández-Álvarez, M., Eslava-Castañeda, J. C., Henao-Kaffure, L., Orozco-Díaz, J., & Parra-Salas, L. E. (2020). Universal health coverage and capital accumulation: a relationship unveiled by the critical political economy approach [Original Article]. International Journal of Public Health, 995–1001. https://doi.org/10.1007/s00038-020-01437-9
dc.relation.referencesHernández Álvarez, M. (2003). Neoliberalismo en salud: desarrollos, supuestos y alternativas. In D. Botero & I. Restrepo (Eds.), La falacia neoliberal: crítica y alternativas (pp. 347-361). Universindad Nacional de Colombia.
dc.relation.referencesHernández, M. (2019). Sistemas universales de protecciones sociales como alternativa a la Cobertura Universal en Salud (CUS). Saúde Debate, 43(5), 29-43. https://doi.org/10.1590/0103-11042019S503
dc.relation.referencesHimmelstein, D. S., Greene, C. S., Romero, A. R., Levernier, J. G., Munro, T. A., McLaughlin, S. R., & Greshake Tzovaras, B. (2018). Sci-Hub provides access to nearly all scholarly literature. eLife, 7. https://doi.org/10.7554/eLife.32822
dc.relation.referencesHolguín Zamorano, G. (2014). La guerra contra los medicamentos genéricos: Un crímen silencioso (Aguilera, Ed. 1 ed.). https://www.mision-salud.org/wp-content/uploads/2015/08/Resumen-Ejecutivo-La-Guerra-contra-los-medicamentos-genericos.pdf
dc.relation.referencesHomedes, N., & Ugalde, A. (2015). El ciclo de los medicamentos: su impacto en el acceso y el uso adecuado [The medication cycle: its impact on access to and adequate use of drugs]. Salud Colectiva, 11(1), 5-8. http://www.redalyc.org/articulo.oa?id=73138582001
dc.relation.referencesHonorato, J. (2007). Diferencias entre medicamentos de síntesis química y de origen biotecnológico. Revista española de Economía de la Salud, 6(6), 334-338.
dc.relation.referencesHospital for Sick Children. (2019). About SickKids: History and milestones 1901-1925. SickKids. Retrieved 30/11/2019 from http://www.sickkids.ca/aboutsickkids/history-and-milestones/milestones/1901-1925/index.html
dc.relation.referencesHughes, S. S. (2011). Genentech: the beginnings of biotech [Book]. University of Chicago Press. https://press.uchicago.edu/ucp/books/book/chicago/G/bo8169877.html
dc.relation.referencesHulse, J. H. (2004). Biotechnologies: past history, present state and future prospects. Trends in Food Science & Technology, 15(1), 3-3-18. https://doi.org/10.1016/S0924-2244(03)00157-2
dc.relation.referencesHurlbut, J. B. (2015). Limits of Responsibility: Genome Editing, Asilomar, and the Politics of Deliberation [Article]. Hastings Center Report, 45(5), 11-14. https://doi.org/10.1002/hast.484
dc.relation.referencesIDF. (2017a). Diabetes Atlas de la FID Octava edición 2017 (International Diabetes Federation, Ed. 8 ed.). International Diabetes Federation,. www.diabetesatlas.org
dc.relation.referencesIDF. (2017b). IDF releases report of global survey on access to medicines and supplies for people with diabetes. Diabetes Research And Clinical Practice, 129, 224-225. https://doi.org/10.1016/j.diabres.2017.06.001
dc.relation.referencesIDF. (2019a). IDF Diabetes Atlas - Nineth edition 2019. International Diabetes Federation. https://www.diabetesatlas.org/en/resources/
dc.relation.referencesIDF. (2019b). International Diabetes Federation. https://www.idf.org/index.php?option=com_attachments&task=download&id=1293:9_WDD_IDF_ES
dc.relation.referencesINAHTA. (2015a). The History of INAHTA. Retrieved 23/05/2015 from http://www.inahta.org/about-inahta/history/
dc.relation.referencesINAHTA. (2015b). What is Health Tecnology? The International Network of Agencies for Health Technology Assessment. http://htaglossary.net/tecnolog%C3%ADa+sanitaria+%28n.f.%29
dc.relation.referencesInstitute of Medicine (US). (2009). Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies. Forum on Drug Discovery, Development, and Translation, Washington (DC).
dc.relation.referencesInstituto de Salud Pública de Chile. (2015). Medicamentos Biológicos: una alternativa para el tratamiento de enfermedades. Retrieved 23/04/2015 from http://www.ispch.cl/noticia/15611
dc.relation.referencesInstituto Nacional de Propiedad Industrial de Chile. (2020). ¿Qué son las patentes? Retrieved 18 de agosto de 2020 from https://www.inapi.cl/portal/institucional/600/fo-article-744.pdf
dc.relation.referencesIriart, C. (2008). Capital financiero versus complejo médico-industrial: los desafíos de las agencias regulatorias. Ciência & Saúde Coletiva, 13(5), 1619-1626. http://www.redalyc.org/articulo.oa?id=63013522
dc.relation.referencesJacob, M. (2003). Rethinking Science and Commodifying Knowledge. Policy Futures in Education, 1(1), 125-142. https://doi.org/10.2304/pfie.2003.1.1.3
dc.relation.referencesJennings, P., & Hussain, S. (2019). Do-It-Yourself Artificial Pancreas Systems: A Review of the Emerging Evidence and Insights for Healthcare Professionals [Article]. Journal Of Diabetes Science And Technology, 0(0), 1-10. https://doi.org/10.1177/1932296819894296
dc.relation.referencesJIFE. (2015). Informe de la Junta Internacional de Fiscalización de Estupefacientes correspondiente a 2014. http://www.unodc.org/documents/colombia/2015/Marzo/AR_2014_S.pdf
dc.relation.referencesJurdjevic, M., & Tillman, C. (2004). E. C. Noble in June 1921, and His Account of the Discovery of Insulin [research-article]. Bulletin Of The History Of Medicine, 78(4), 864-875. https://doi.org/10.1353/bhm.2004.0175
dc.relation.referencesKalra, S. (2013). Diabesity. Recent Advances in Endocrinology, 63(4), 532-534. https://jpma.org.pk/PdfDownload/4131
dc.relation.referencesKaplan, W., & Beall, R. (2016). Insulin patent profile. Health Action International. https://haiweb.org/wp-content/uploads/2016/04/ACCISS-PatentReport-FINAL.pdf
dc.relation.referencesKarakilic, E. (2019). Rethinking intellectual property rights in the cognitive and digital age of capitalism: An autonomist Marxist reading [Journal Article]. Technological Forecasting and Social Change, 147, 1-9. https://doi.org/10.1016/j.techfore.2019.06.007
dc.relation.referencesKaramitsos, D. T. (2011). The story of insulin discovery. Diabetes Research And Clinical Practice, 93, S2-S8. https://doi.org/10.1016/S0168-8227(11)70007-9
dc.relation.referencesKeulartz, J., & van den Belt, H. (2016). DIY-Bio - economic, epistemological and ethical implications and ambivalences. Life sciences, society and policy, 12(1), 1-19. https://doi.org/10.1186/s40504-016-0039-1
dc.relation.referencesKing, K. M. (2003). A history of insulin: from discovery to modern alternatives [Article]. British journal of nursing (Mark Allen Publishing), 12(19), 1137-1141. https://doi.org/10.12968/bjon.2003.12.19.11801
dc.relation.referencesKing, K. M., & Rubin, G. (2003). A history of diabetes: from antiquity to discovering insulin [Article]. British journal of nursing (Mark Allen Publishing), 12(18), 1091-1095. https://doi.org/10.12968/bjon.2003.12.18.11775
dc.relation.referencesKleiner, I. S. (1919). The action of intravenous injections of pancreas emulsions in experimental diabetes. The Journal of Biological Chemistry(40), 153-170. http://www.jbc.org/content/40/1/153.full.pdf
dc.relation.referencesKlingle, M. (2018). The Multiple Lives of Marjorie: The Dogs of Toronto and the Co-Discovery of Insulin. Environmental History, 23(2), 368-382. https://doi.org/10.1093/envhis/emx134
dc.relation.referencesKneller, R. (2010). The importance of new companies for drug discovery: origins of a decade of new drugs. Nature Reviews Drug Discovery, 9(11), 867-882. https://doi.org/10.1038/nrd3251
dc.relation.referencesKreimer, P. (2006). ¿Dependientes o integrados?: La ciencia latinoamericana y la nueva división internacional del trabajo. Nómadas(24), 199-212. http://www.redalyc.org/articulo.oa?id=105116598017
dc.relation.referencesKreimer, P., & Corvalán, D. (2009). 20 años no es nada: Conocimiento científico, producción de medicamentos y necesidades sociales [research-article]. Desarrollo Económico, 49(193), 123-149. https://www.jstor.org/stable/20627865
dc.relation.referencesKruse, S., Slomiany, M., Bitar, R., Jeffers, S., & Hassan, M. (2014). Pharmaceutical R&D productivity: the role of alliances [Report]. Journal of Commercial Biotechnology(2), 11. https://doi.org/10.5912/jcb632
dc.relation.referencesKukso, F. (2020). Sci-hub. Quién es la Robin Hood de la ciencia que creó este sitio pirata. La Nación. https://www.lanacion.com.ar/lifestyle/sci-hub-quien-es-la-robin-hood-de-la-ciencia-que-creo-este-sitio-pirata-nid2372230
dc.relation.referencesKurtz, R. (2019). Pharmaceutical Innovation: Eli Lilly and Company, the University of Toronto, and the Development of Insulin. University of Indianapolis. https://www.in.gov/history/files/Kurtz,%20Reagan.pdf
dc.relation.referencesLaín Entralgo, P. (1978). Historia de la medicina (Vol. 21) [Regular print reproduction / Non-fiction]. Salvat.
dc.relation.referencesLarivière, V., Haustein, S., & Mongeon, P. (2015). The Oligopoly of Academic Publishers in the Digital Era [Journal Article]. Plos One, 10(6), 1-15. https://doi.org/10.1371/journal.pone.0127502
dc.relation.referencesLaurell, A. C. (1994). Sobre la Concepción Biológica y Social del Proceso Salud Enfermedad. In OPS (Ed.), Lo biológico y lo social: Su articulación en la formación del personal de salud (pp. 1-12). OPS. http://hist.library.paho.org/Spanish/DRH/21485.pdf
dc.relation.referencesLavalle-Gonzalez, F. J., & Khatami, H. (2014). The Biosimilar Insulin Landscape: Current Developments. Postgraduate Medicine, 126(6), 81-92. https://doi.org/10.3810/pgm.2014.10.2823
dc.relation.referencesLema Spinelli, S. (2015). Acceso a los medicamentos: las patentes y los medicamentos genéricos: las consecuencias de considerar al medicamento como un bien de mercado y no social [Access to medicines: patents and generic drugs. The consequences of considering drugs as a market commodity and not as a social value]. Revista de Bioética y Derecho(34), 81-89. https://doi.org/10.1344/rbd2015.34.12068
dc.relation.referencesLévy, M. (2017). Le capitalisme philanthropique : un certain renouveau de la solidarité internationale. Annales des Mines - Responsabilité et environnement, 88(4), 78-81. https://doi.org/10.3917/re1.088.0078
dc.relation.referencesLewis, D. (2019). History and Perspective on DIY Closed Looping [Note]. Journal Of Diabetes Science And Technology, 13(4), 790-793. https://doi.org/10.1177/1932296818808307
dc.relation.referencesLewis, D. M. (2020). Do-It-Yourself Artificial Pancreas System and the OpenAPS Movement [Review Article]. Endocrinology and Metabolism Clinics of North America, 49(1), 203-213. https://doi.org/10.1016/j.ecl.2019.10.005
dc.relation.referencesLexchin, J. (2012). Harmony in drug regulation, but who's calling the tune? An examination of regulatory harmonization in Health Canada. International Journal of Health Services, 42(1), 119-136. http://www.jstor.org/stable/45140255
dc.relation.referencesLight, D. W., & Lexchin, J. R. (2012). Pharmaceutical research and development: what do we get for all that money? British Medical Journal, 344, e43-e48. https://doi.org/10.1136/bmj.e4348
dc.relation.referencesLiljeblad, J. (2016). Understanding the Complexities of Civil Disobedience for Cyberspace Protests in the Case of Aaron Swartz. Rutgers Computer and Technology Law Journal, 42(2), 196-230. http://hdl.handle.net/1959.3/433553
dc.relation.referencesLinares-Pérez, N., & López-Arellano, O. (2008). La equidad en salud: propuestas conceptuales, aspectos críticos y perspectivas desde el campo de la salud colectiva. Medicina Social, 3(3), 247-259. http://www.socialmedicine.info/index.php/medicinasocial/article/viewFile/226/484
dc.relation.referencesLondon, J. (2014). Tragedy, transformation, and triumph: comparing the factors and forces that led to the adoption of the 1860 Adulteration Act in England and the 1906 Pure Food and Drug Act in the United States [Article]. Food and drug law journal, 69(2), 315-342. https://pubmed.ncbi.nlm.nih.gov/25163213/
dc.relation.referencesLudlow, P. (2013). Hacktivist witch hunt [Article]. Nation, 297(26/27), 23-26. http://ezproxy.javeriana.edu.co:2048/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=a9h&AN=92763848&lang=es&site=eds-live
dc.relation.referencesMachin-Mastromatteo, J. D., Romero-Ortiz, M. E., & Uribe-Tirado, A. (2016). Piracy of scientific papers in Latin America: An analysis of Sci-Hub usage data [Article]. Information Development, 32(5), 1806-1814. https://doi.org/10.1177/0266666916671080
dc.relation.referencesMadar, C. (2013). The Death of Aaron Swartz. The Nation, 296, 4-5. http://search.ebscohost.com/login.aspx?direct=true&db=a9h&AN=85098284&site=eds-live
dc.relation.referencesMaddox, B. (2003). The double helix and the 'wronged heroine'. Nature, 421(6921), 407-408. https://doi.org/10.1038/nature01399
dc.relation.referencesMadeb, R., Koniaris, L. G., & Schwartz, S. I. (2005). The discovery of insulin: the Rochester, New York, connection [Journal Article]. Annals of Internal Medicine, 143(12), 907-912. https://doi.org/10.7326/0003-4819-143-12-200512200-00009
dc.relation.referencesMadison, J. H. (1989). Manufacturing Pharmaceuticals: Eli Lilly and Company, 1876-1948 [Journal Article]. Business and Economic History, 18, 72. http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.392.2996&rep=rep1&type=pdf
dc.relation.referencesMadrid, L. B. (2011). Realizando "diagnósticos diferenciales" de los modelos teóricos del proceso salud-enfermedad. KAIROS Revista de Temas Sociales, 15(28), 1-13. http://www.revistakairos.org/wp-content/uploads/Madrid.pdf
dc.relation.referencesManiglio, F. (2017). La injusticia cognitiva en la división internacional del conocimiento. El caso de la migración altamente cualificada [Cognitive Injustice in the International Division of Knowledge. The Case of Highly Skilled Migration / L’injustice cognitive dans le partage international du savoir. Le cas de la migration hautement qualifiée]. Revista Crítica de Ciências Sociais(114), 27-46. https://doi.org/10.4000/rccs.6747
dc.relation.referencesMarazzi, C. (2011). The Violence of Financial Capitalism (K. Lebedeva & J. F. Mc Gimsey, Trans.) [Book]. Semiotext(e). http://search.ebscohost.com/login.aspx?direct=true&db=eoh&AN=1104010&site=eds-live
dc.relation.referencesMartín-Cabello, A. (2013). Sobre los orígenes del proceso de globalización [On the origins of the globalization process]. Methaodos Revista de Ciencias Sociales, 1(1), 7-20. https://doi.org/10.17502/m.rcs.v1i1.22
dc.relation.referencesMarx, K. (2014). El capital. crítica de la economía política (W. Roces, Trans.; 4a ed. ed., Vol. I) [Non-fiction]. Fondo de Cultura Económica.
dc.relation.referencesMax Planck Gesellschaft. (2003). Berlin Declaration on Open Access to Knowledge in the Sciences and Humanities. https://openaccess.mpg.de/Berlin-Declaration
dc.relation.referencesMcKinsey & Company. (2013). Beyond the storm: Launch excellence in the new normal. https://www.mckinsey.com/~/media/mckinsey/industries/healthcare%20systems%20and%20services/our%20insights/the%20secret%20of%20successful%20drug%20launches/beyond_the_storm_launch_excellence_in_the_new_normal.pdf
dc.relation.referencesMcQuaig, L. (2020). The public lab that could have helped fight COVID-19? [Article]. Canadian Centre for Policy Alternatives Monitor, 26(7), 15-15. https://login.ezproxy.javeriana.edu.co/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=a9h&AN=143036942&lang=es&site=eds-live
dc.relation.referencesMedbelle. (2021). 2019 Medicine Price Index. Retrieved 01 de junio de 2021 from https://www.medbelle.com/medicine-price-index/
dc.relation.referencesMédicos sin Fronteras. (2001). Desequilibrio Mortal: La crisis de la investigación y el desarrollo de medicamentos para enfermedades olvidadas. https://www.msf.fr/sites/default/files/2001-10-15-CAME3.pdf
dc.relation.referencesMédicos sin Fronteras. (2012). Contra el olvido. MSF. https://www.msf.es/sites/default/files/legacy/adjuntos/Contra-el-olvido-informe-mayo2012.pdf
dc.relation.referencesMédicos sin Fronteras. (2015a). Access Campaign. Retrieved 23/05 from http://www.msfaccess.org/
dc.relation.referencesMédicos sin Fronteras. (2015b). Las reservas de antídotos para las mordeduras de serpiente se agotan. http://www.msf.es/noticia/2015/reservas-antidotos-para-mordeduras-serpiente-se-agotan
dc.relation.referencesMédicos sin Fronteras. (2015c). Snakebite how a public health emergency slithered under the radar. http://www.msf.org.uk/sites/uk/files/bpsnakebite_070915_en_0.pdf
dc.relation.referencesMedicus Mundi. (2008). Acceso a los medicamentos: Dossier de contenidos (Salut per al desenvolupament, Issue. http://www.farmaceuticosmundi.org/farmamundi/descargas/pdf/CAMPA%D1AS-ACTIVIDADES/DOSIER%20MEDICAMENTOS%20ESENCIALES.pdf
dc.relation.referencesMelero, R. (2005). Acceso abierto a las publicaciones científicas: definición, recursos, copyright e impacto [Open access to scientific publications: definition, resources, copyright and impact] [Article]. El Profesional de la Informacion, 14(4), 255-266. https://doi.org/10.3145/epi.2005.jul.03
dc.relation.referencesMelo, J. O. (2008). La idea del progreso en el siglo XIX, ilusiones y desencantos, 1780-1930 XVI Congreso de colombianistas, Charlottesville, Estados Unidos. http://www.jorgeorlandomelo.com/bajar/progreso1.pdf
dc.relation.referencesMendel, G. (1911). Versuche über Pflanzenhybriden : zwei Abhandlungen (1866 und 1870). Wilhelm Engelmann. http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/9193
dc.relation.referencesMenéndez, E. L. (2003). Modelos de atención de los padecimientos: de exclusiones teóricas y articulaciones prácticas. Ciência & Saúde Coletiva, 8(1), 185-207. http://www.scielo.br/pdf/csc/v8n1/a14v08n1.pdf
dc.relation.referencesMenéndez, E. L. (2005). El Modelo Médico y la Salud de los Trabajadores. Salud Colectiva, 1(1), 9-32. https://www.redalyc.org/pdf/731/73110102.pdf
dc.relation.referencesMerkley, R. (2016). You Pay to Read Research You Fund. That's Ludicrous. Wired. https://www.wired.com/2016/04/stealing-publicly-funded-research-isnt-stealing/
dc.relation.referencesMíguez, P. (2013). Del General Intellect a las tesis del “capitalismo cognitivo”: aportes para el estudio del capitalismo del siglo XXI. Revista Bajo el Volcán, 13(21), 27-57. http://www.redalyc.org/articulo.oa?id=28640302003
dc.relation.referencesMíguez, P. (2018). La propiedad intelectual y la mercantilización forzada del conocimiento [Intellectual property and the forced commodification of knowledge]. Universitas, XVI(29), 43-65. https://doi.org/10.17163/uni.n29.2018.02
dc.relation.referencesMíguez, P. (2016). Trabajo cognitivo: genealogía y aportes de un debate para pensar los procesos de valorización del capital contemporáneos desde la sociología del trabajo y la economía política [Cognitive labor: genealogy and contributions of a debate to think contemporary capital valuation processes from sociology of work and political economy]. Revista da ABET, 15(2), 7-25. http://periodicos.ufpb.br/index.php/abet/article/view/32866
dc.relation.referencesMíguez, P. (2018). La propiedad intelectual y la mercantilización forzada del conocimiento [Intellectual property and the forced commodification of knowledge]. Universitas, XVI(29), 43-65. https://doi.org/10.17163/uni.n29.2018.02
dc.relation.referencesMiller, R. J. (2013). Drugged : The Science and Culture Behind Psychotropic Drugs [Book]. Oxford University Press. http://ezproxy.javeriana.edu.co:2048/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=edsebk&AN=669976&lang=es&site=eds-live
dc.relation.referencesMiller, R. J. (2013). Drugged : The Science and Culture Behind Psychotropic Drugs [Book]. Oxford University Press. http://ezproxy.javeriana.edu.co:2048/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=edsebk&AN=669976&lang=es&site=eds-live
dc.relation.referencesMinisterio de Salud. (1993). Resolución 8430 de 1993 “Por la cual se establecen las normas científicas, técnicas y administrativas para la investigación en salud”. http://www.minsalud.gov.co/Normatividad/RESOLUCION%208430%20DE%201993.pdf
dc.relation.referencesMinisterio de Salud. (2020a). Cifras del aseguramiento en salud con corte septiembre de 2020. Minsalud. Retrieved 27/10/2020 from https://www.minsalud.gov.co/proteccionsocial/Paginas/cifras-aseguramiento-salud.aspx
dc.relation.referencesResolución No. 2481 de 2020, 147 (2020b). https://www.minsalud.gov.co/Paginas/Se-actualiza-Plan-de-Beneficios-en-Salud-con-cargo-a-la-UPC.aspx
dc.relation.referencesMinisterio de Salud y Protección Social. (2014). ABECÉ sobre medicamentos biotecnológicos. Retrieved 12/05/2015 from https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/MET/abc-biomedicamentos.pdf
dc.relation.referencesMittra, J. (2016). The New Health Bioeconomy: R&D Policy and Innovation for the Twenty-First Century (1 ed.) [eBook]. Palgrave Macmillan US. https://doi.org/10.1057/9781137430526
dc.relation.referencesMoati, P., & Mouhoud, E. M. (2005). Les nouvelles logiques de décomposition internationale des processus productifs [research-article]. Revue d'économie politique, 115(5), 573-589. https://doi.org/10.3917/redp.155.0573
dc.relation.referencesMoncayo, H. L., Libreros, D., Moncayo, V. M., Quevedo, R., Agudelo, M., & Zerda Sarmiento, Á. (2010). Trabajo y capital en el siglo XXI (1 ed.). Instituto Latinoamericano de Servicios Legales (ILSA). http://biblioteca.clacso.edu.ar/Colombia/ilsa/20130822030642/hector.pdf
dc.relation.referencesMoore, J. W. (2016). Anthropocene or capitalocene? nature, history, and the crisis of capitalism [Book]. Kairos PM Press. http://ezproxy.javeriana.edu.co:2048/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=cat01040a&AN=pujbc.915534&lang=es&site=eds-live
dc.relation.referencesMorgan, T. (1928). The Theory of the Gen. Yale University Press. http://www.esp.org/books/morgan/theory/facsimile/contents/morgan-theory-aa-fm.pdf
dc.relation.referencesMouhoud, E. M., & Plihon, D. (2007). Finance et économie de la connaissance : Des relations équivoques. Innovations(25), 9-43. https://www.cairn.info/revue-innovations-2007-1-page-9.htm#
dc.relation.referencesMoulier Boutang, Y. (2011). Cognitive capitalism [Le Capitalisme Cognitif] (E. Emery, Trans.) [Book]. Polity Press.
dc.relation.referencesMulet, J. M. (2013). La historia de la insulina, 90 años salvando vidas. Web Naukas.com. Retrieved 07 de octubre de 2019 from https://culturacientifica.com/2013/04/19/la-historia-de-la-insulina-90-anos-salvando-vidas/
dc.relation.referencesMuthukumaran, K. (2019). Insulin biosimilars [Article]. Medical Writing, 28(2), 57-59. https://journal.emwa.org/generics-and-biosimilars/insulin-biosimilars/
dc.relation.referencesNadal, A. (2012). El mundo de la obesidad en el capitalismo tardío. La Jornada. https://www.jornada.com.mx/2012/08/15/economia/032a1eco
dc.relation.referencesNagendrappa, G. (2010). Sir William Henry Perkin: The man and his 'Mauve' [Article]. Resonance, 15(9), 779-793. https://doi.org/10.1007/s12045-010-0088-3
dc.relation.referencesNambisan, P. (2017). Chapter 15 - Patents in Biopharma [Book Chapter]. An Introduction to Ethical, Safety and Intellectual Property Rights Issues in Biotechnology, 329-344. https://doi.org/10.1016/B978-0-12-809231-6.00015-6
dc.relation.referencesNational Human Genome Research Institute. (2020). ADN (Ácido Desoxirribonucleico). Retrieved 10/03/2020 from https://www.genome.gov/es/genetics-glossary/ADN-acido-Desoxirribonucleico
dc.relation.referencesNational Kidney Foundation. (2007). La diabetes y la insuficiencia renalcrónica (Falla crónica del riñón). National Kidney Foundation. https://www.kidney.org/sites/default/files/docs/diabckd-stg5_span.pdf
dc.relation.referencesNegri, A., & Vercellone, C. (2008). Le rapport capital / travail dans le capitalisme cognitif [article]. Multitudes(32), 39-50. https://doi.org/10.3917/mult.032.0039
dc.relation.referencesNewell-McGloughlin, M., & Re, E. (2006). The Evolution of Biotechnology : From Natufians to Nanotechnology. Springer. https://doi.org/10.1007/1-4020-5149-2
dc.relation.referencesNils, R.-H. (2009). Sources of Wilhelm Johannsen's Genotype Theory [research-article]. Journal of the History of Biology, 42(3), 457-493. https://doi.org/10.1007/s10739-008-9166-8
dc.relation.referencesNovo Nordisk. (2011). Novo Nordisk History (3 ed.). Novo Nordisk,. https://www.novonordisk.com/content/dam/Denmark/HQ/aboutus/documents/HistoryBook_UK.pdf
dc.relation.referencesNovo Nordisk. (2018). Los Fundadores. Novo Nordisk Pharma, S.A. Retrieved 2019/12/07 from https://www.novonordisk.es/sobre-novo-nordisk/novo-nordisk-historia/los-fundadores.html
dc.relation.referencesObservatorio Nacional de Salud. (2015). Carga de enfermedad por Enfermedades Crónicas No Transmisibles y Discapacidad en Colombia (Informe técnico, Issue. https://www.ins.gov.co/Direcciones/ONS/Informes/5.%20Carga%20de%20enfermedad%20ECNT.pdf
dc.relation.referencesOdeh, L. E. (2010). A comparative analysis of Global North and Global South economies. Journal of Sustainable Development in Africa, 12(3), 338-348.
dc.relation.referencesOliveira, L. (2000). Commodification of Science and Paradoxes in Universities [Article]. Science Studies, 13(2), 23. https://doi.org/10.23987/sts.55125
dc.relation.referencesOMPI. (2020a). ¿Qué es la Propiedad Intelectual? https://www.wipo.int/edocs/pubdocs/es/intproperty/450/wipo_pub_450.pdf
dc.relation.referencesOMPI. (2020b). Reseña histórica de la OMPI. https://www.wipo.int/about-wipo/es/history.html
dc.relation.referencesOMS. (2015). Medicamentos esenciales. Retrieved 03/09/2015 from http://www.who.int/topics/essential_medicines/es/
dc.relation.referencesOMS. (2016). Informe mundial sobre la diabetes (OMS, Ed.). OMS. https://apps.who.int/iris/bitstream/handle/10665/254649/9789243565255-spa.pdf?sequence=1
dc.relation.referencesOMS. (2018). Enfermedades no transmisibles. OMS. Retrieved 17 de marzo de 2019 from https://www.who.int/es/news-room/fact-sheets/detail/noncommunicable-diseases
dc.relation.referencesONU-OMS. (2018). Es hora de actuar: Tercera Reunión de Alto Nivel de las Naciones Unidas sobre las Enfermedades No Transmisibles http://origin.who.int/ncds/governance/third-un-meeting/brochure-es.pdf
dc.relation.referencesONU. (2007). La salud y los objetivos de desarrollo del Milenio: Los retos del futuro. Retrieved 26/09/2015 from http://unchronicle.un.org/es/article/la-salud-y-los-objetivos-de-desarrollo-del-milenio-los-retos-del-futuro/
dc.relation.referencesONU. (2010). Enfermedades relacionadas con el estilo de vida: Una carga económica para los servicios de salud. Crónica ONU, XLVII(2). https://www.un.org/es/chronicle/article/enfermedades-relacionadascon-el-estilo-de-vida-una-carga-economica-para-los-servicios-de-salud
dc.relation.referencesONU. (2015). Cumbre de las Naciones Unidas sobre el desarrollo sostenible 2015. Retrieved 26/09/2015 from http://www.un.org/sustainabledevelopment/es/summit/
dc.relation.referencesONU. (2016). Informe del Grupo de Alto Nivel del Secretario General de las Naciones Unidas Sobre el Acceso a los Medicamentos: Promover la innovación y el acceso a las tecnologías de la salud. http://www.unsgaccessmeds.org/final-report
dc.relation.referencesONU. (2018). Declaración política de la Tercera Reunión de Alto Nivel de la Asamblea General sobre la Prevención y el Control de las Enfermedades No Transmisibles (A/RES/73/2). https://undocs.org/pdf?symbol=es/A/RES/73/2
dc.relation.referencesOPS. (2008). Guía práctica de investigación en salud. http://www.bvsde.paho.org/texcom/cd045364/PC620.pdf
dc.relation.referencesOrdóñez, E. J. (2014). La desobediencia civil en tanto disidencia. Thoreau, Arendt, Rawls [Civil disobedience as dissent. Thoreau, Arendt, Rawls]. Revista de Filosofía UIS, 13(1), 123-137. https://www.redalyc.org/pdf/343/34301502.pdf
dc.relation.referencesOrueta Sánchez, R., Santos Rodríguez, C., González Hidalgo, E., Fagundo Becerra, E. M., Alejandre Lázaro, G., Carmona de la Morena, J., Rodríguez Alcalá, J., Campo del Campo, J. M. d., Díez Andrés, M. L., Vallés Fernández, N., & Butrón Gómez, T. (2011). Medicalización de la vida (I). Revista Clínica de Medicina de Familia, 4, 150-161. http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1699-695X2011000200011&nrm=iso
dc.relation.referencesOttersen, O. P., Dasgupta, J., Blouin, C., Buss, P., Chongsuvivatwong, V., Frenk, J., Fukuda-Parr, S., Gawanas, B. P., Giacaman, R., Gyapong, J., Leaning, J., Marmot, M., McNeill, D., Mongella, G. I., Moyo, N., Møgedal, S., Ntsaluba, A., Ooms, G., Bjertness, E., Lie, A. L., Moon, S., Roalkvam, S., Sandberg, K. I., & Scheel, I. B. (2014). The political origins of health inequity: prospects for change. The Lancet, 383(9917), 630-667. https://doi.org/10.1016/S0140-6736(13)62407-1
dc.relation.referencesOwens, D. R. (1986). Human Insulin: Clinical Pharmacological Studies in Normal Man. MTP Press Limited. https://doi.org/10.1007/978-94-009-4161-8
dc.relation.referencesOXFAM. (2015). La desigualdad extrema de las emisiones de carbono https://www.oxfam.org/sites/www.oxfam.org/files/file_attachments/mb-extreme-carbon-inequality-021215-es.pdf
dc.relation.referencesPagés, J. A. (2013). Los medicamentos esenciales: una mirada de algunos hitos en los últimos cuarenta años (1975-2013) [Essential medicines: an overview of some milestones in the last forty years (1975-2013)]. Medwave, 13(5), e5733. https://doi.org/10.5867/medwave.2013.05.5733
dc.relation.referencesPalomar Bonet, M. (2011). Medicamentos Biotecnológicos. Revista MoleQla(3). Retrieved 27/09/2015, from https://www.upo.es/cms1/export/sites/upo/moleqla/documentos/NUMERO3_COMPLETO.pdf
dc.relation.referencesParascandola, J. (1985). Industrial research comes of age: the American pharmaceutical industry, 1920-1940 [Article]. Pharmacy in History, 27(1), 12-21. https://www.jstor.org/stable/41110167
dc.relation.referencesPaule, C. (2010). La salud pública en la época del capitalismo filantrópico La inversión en los PVD por parte de la Fundación Gates. Retrieved 06 de junio de 2021 from http://www.chaos-international.org/la-salud-publica-en-la-epoca-del-capitalismo-filantropico/?lang=es
dc.relation.referencesPaulesco, N. C. (1921). Recherches sur le rôle du pancréas dans l’assimilation nutritive. Archives Internationales de Physiologie(17), 85-109. https://insulin.library.utoronto.ca/islandora/object/insulin%3AT10137
dc.relation.referencesPaulré, B. (2000). De la 'New economy' au capitalisme cognitif [article]. Multitudes(2), 25-42. https://doi.org/10.3917/mult.002.0025
dc.relation.referencesPedraza, F. P. (2010). La vigencia de la gran transformación de Karl Polanyi: del capitalismo post-fordista al mundo comunitario [text]. https://mdc.ulpgc.es/cdm/ref/collection/bolmc/id/434
dc.relation.referencesPedrique, B., Strub-Wourgaft, N., Some, C., Olliaro, P., Trouiller, P., Ford, N., Pécoul, B., & Bradol, J.-H. (2013). The drug and vaccine landscape for neglected diseases (2000–11): a systematic assessment [Journal Article]. The Lancet Global Health, 1, e371-e379. https://doi.org/10.1016/S2214-109X(13)70078-0
dc.relation.referencesPerrone, I., & Zukerfeld, M. (2007). Disonancias del Capital: Música, Tecnologías Digitales y Capitalismo (1a. Ed. ed.). Ediciones Cooperativas. https://repositorio.esocite.la/75/1/Perrone-y-Zukerfeld-2007-Disonancias-del-Capital.pdf
dc.relation.referencesPeters, M. A. (2012). Bio-informational capitalism [Article]. Thesis Eleven, 110(1), 98-111. https://doi.org/10.1177/0725513612444562
dc.relation.referencesPeters, M. A., & Venkatesan, P. (2010). Biocapitalism and the politics of life. Geopolitics, History & International Relations, 2(2), 100-122. http://search.proquest.com/docview/851301324?accountid=13250
dc.relation.referencesPeters, M. A., & Venkatesan, P. (2011). Bioeconomy and third industrial revolution in the age of synthetic life [Article]. Contemporary Readings in Law & Social Justice, 2(2), 148-162. http://search.ebscohost.com/login.aspx?direct=true&db=a9h&AN=58713107&lang=es&site=eds-live
dc.relation.referencesPiñeiro, F., Chiarante, N., & Zelaya, M. (2020). Sobre la investigación, desarrollo y producción pública de nuevos medicamentos [article]. Ciencia, Tecnología y Política, 3(4), 1-8. https://doi.org/10.24215/26183188e040
dc.relation.referencesPitts, F. H. (2018). Critiquing Capitalism Today : New Ways to Read Marx (M. Musto & T. Carver, Eds.) [Book]. Palgrave Macmillan. https://doi.org/10.1007/978-3-319-62633-8
dc.relation.referencesPNUD. (2015). Una nueva agenda de desarrollo sostenible. Retrieved 26/09/2015 from http://www.undp.org/content/undp/es/home/mdgoverview.html
dc.relation.referencesPochmann, M. (2011). La fuga de cerebros y la nueva división internacional del trabajo [The Brain Drain and the New International Labor Division]. Revista Nueva Sociedad(233), 98-113. https://nuso.org/articulo/la-fuga-de-cerebros-y-la-nueva-division-internacional-del-trabajo/
dc.relation.referencesPolanyi, K. (1989). La gran transformación. crítica del liberalismo económico [Regular print reproduction Non-fiction]. La Piqueta. http://paje.fe.usp.br/~mbarbosa/dpi/polanyigt.pdf
dc.relation.referencesPopko, L. (2018). Some Notes on Papyrus Ebers, Ancient Egyptian Treatments of Migraine, and a Crocodile on the Patient's Head. Bulletin Of The History Of Medicine, 92(2), 352-367. https://doi.org/10.1353/bhm.2018.0030
dc.relation.referencesPortin, P. (2014). The birth and development of the DNA theory of inheritance: sixty years since the discovery of the structure of DNA [Journal Article]. Journal of Genetics, 93(1), 293-302. https://doi.org/10.1007/s12041-014-0337-4
dc.relation.referencesPrescrire International. (2010). ICH: an exclusive club of drug regulatory agencies and drug companies imposing its rules on the rest of the world [ICH: un club exclusivo de agencias reguladoras de fármacos y compañías farmacéuticas que imponen sus reglas al resto del mundo.]. Prescrire International, 19(108), 183-186. https://webcache.googleusercontent.com/search?q=cache:_37avESajNkJ:https://www.saludyfarmacos.org/lang/es/boletin-farmacos/boletines/feb2011/ich-un-clubexclusivo+&cd=12&hl=es-419&ct=clnk&gl=co&client=firefox-b-d
dc.relation.referencesPrescrire International. (2020). Drug research: public funding, private profits. Prescrire International, 29(221), 303-306. https://english.prescrire.org/en/81/168/60489/0/NewsDetails.aspx?page=1
dc.relation.referencesProject Open Insulin. (2020). About the project. Retrieved 03/01/2020 from https://openinsulin.org/about-the-project/
dc.relation.referencesQuevedo V., E., & Hernández A., M. (1994). La Articulación del Conocimiento Básico Biológico y Social en la Formación del Profesional de la Salud: Una Mirada desde la Historia. In M. I. Rodríguez (Ed.), Lo biológico y lo social - su articulación en la formación del personal de salud (1 ed., pp. 13-34). Organización Panamericana de la Salud. https://iris.paho.org/bitstream/handle/10665.2/3095/Lo%20biologico%20y%20lo%20social.pdf?sequence=1&isAllowed=y
dc.relation.referencesRadder, H. (2010). The Commodification of Academic Research : Science and the Modern University [Book]. University of Pittsburgh Press. https://login.ezproxy.javeriana.edu.co/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=e000xww&AN=829286&lang=es&site=eds-live
dc.relation.referencesRahman, I. U., Afzal, A., Iqbal, Z., Ijaz, F., Ali, N., Shah, M., Ullah, S., & Bussmann, R. W. (2019). Historical perspectives of ethnobotany [Review Article]. Clinics in Dermatology, 37(4), 382-388. https://doi.org/10.1016/j.clindermatol.2018.03.018
dc.relation.referencesRajkumar, S. V. (2020). The High Cost of Insulin in the United States: An Urgent Call to Action. Mayo Clinic Proceedings, 95(1), 22-28. https://doi.org/10.1016/j.mayocp.2019.11.013
dc.relation.referencesRamiro, P., & González, E. (2013). Empresas transnacionales: impactos y resistencias. Revista El Ecologista(77), 0-0. https://www.ecologistasenaccion.org/publicaciones/revista/no-77/#outil_sommaire_1
dc.relation.referencesRao, C. K. (2008). Who coined the terms 'biotechnology' and 'genetic engineering', and when? [Letter]. Current Science, 95(11), 1512-1513. https://www-jstor-org.ezproxy.unal.edu.co/stable/24105492
dc.relation.referencesRasmussen, N. (2004). The Moral Economy of the Drug Company–Medical Scientist Collaboration in Interwar America [Journal Article]. Social Studies Of Science, 34(2), 161-185. https://doi.org/10.1177/0306312704042623
dc.relation.referencesRelman, A. S. (1980). The New Medical-Industrial Complex [Journal Article]. New England Journal of Medicine, 303(17), 963-970. https://doi.org/10.1056/NEJM198010233031703
dc.relation.referencesRezende, P. A. (2013). Aaron Swartz faces Cyberpharisees: The First Martyr of Cyberwar. https://www.cic.unb.br/~pedro/trabs/aaron-en.html
dc.relation.referencesRiddle, J. M. (1985). Dioscorides on Pharmacy and Medicine (Vol. 1st ed) [Book]. University of Texas Press. http://ezproxy.javeriana.edu.co:2048/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=edsebk&AN=1479190&lang=es&site=eds-live
dc.relation.referencesRiedlinger, S., Giustini, D., & Hursh, B. (2018). Part I: The impact of insulin on children with diabetes at Toronto Sick Kids in the 1920s. Hektoen International Journal. Retrieved 30/11/2019 from https://hekint.org/2018/05/15/part-i-the-impact-of-insulin-on-children-with-diabetes-at-toronto-sick-kids-in-the-1920s/
dc.relation.referencesRodríguez Hernández, J. M., Rodríguez Rubiano, D. P., & Corrales Barona, J. C. (2015). Barreras de acceso administrativo a los servicios de salud en población Colombiana, 2013 [Journal Article]. Revista Ciência & Saúde Coletiva, 20(6), 1947-1947-1958. https://doi.org/10.1590/1413-81232015206.12122014
dc.relation.referencesRojas, D. H., Delgado Boada, J., Garzón Bedoya, K., & Ruiz, C. F. (2011). Propuesta de decreto para la aprobación de medicamentos biotecnológicos en colombia. http://asinfar.com/Archivos/PROPUESTA_DE_REGULACION_BIOTECNOLOGICOS.pdf
dc.relation.referencesRollo, J. (1797). An account of two cases of the diabetes mellitus: with remarks (Vol. I) [Monograph]. British Library. https://archive.org/details/b21469179_0001
dc.relation.referencesRose, N. (2012). Políticas de la vida: Biomedicina, poder y subjetividad en el siglo XXI (E. Luján Odriozola, Trans.; 1 ed.) [Book]. UNIPE Editorial Universitaria. (The Politics of Life itself. Biomedicine, Power and Subjectivity in the Twenty-First Century)
dc.relation.referencesRosenberg, E. (2017). Genetic Engineering. In E. Rosenberg (Ed.), It's in Your DNA (pp. 81-93). Academic Press. https://doi.org/10.1016/B978-0-12-812502-1.00010-X
dc.relation.referencesRosenthal, E. (2019). When High Prices Mean Needless Death. JAMA Internal Medicine, 179(1), 114-115. https://doi.org/10.1001/jamainternmed.2018.5007
dc.relation.referencesRostène, W., & De Meyts, P. (2021). Insulin: a 100-Year-Old Discovery With a Fascinating History. Endocrine Reviews, XX(XX), 1–25. https://doi.org/10.1210/endrev/bnab020
dc.relation.referencesRoth, J., Qureshi, S., Whitford, I., Vranic, M., Kahn, C. R., Fantus, I. G., & Dirks, J. H. (2012). Insulin's discovery: new insights on its ninetieth birthday. Diabetes/Metabolism Research And Reviews, 28(4), 293-304. https://doi.org/10.1002/dmrr.2300
dc.relation.referencesRovira Forns, J. (2015). Precios de los medicamentos: cómo se establecen y cuáles son sus sistemas de control [Drug prices: how they are established and existing price control systems] [Journal Article]. Salud Colectiva, 11(1), 14-35. http://revistas.unla.edu.ar/saludcolectiva/article/view/414/430
dc.relation.referencesRovira Forns, J., Gómez Pajuelo, P., & del Llano Señarís, J. (2012). La regulación del precio de los medicamentos en base al valor. Fundación Gaspar Casal, para la investigación y el desarrollo de la salud. http://www.fgcasal.org/publicaciones/Lilly_FGC-Libro_La_Regulacion_del_precio_medicamentos.pdf
dc.relation.referencesRullani, E. (2000). Le capitalisme cognitif : du déjà vu ? [Journal Article]. Multitudes(2), 87-94. https://doi.org/10.3917/mult.002.0087
dc.relation.referencesRutty, C. J. (2008). Personality, Politics, and Canadian Public Health: The Origins of Connaught Medical Research Laboratories, University of Toronto, 1888–1917. In E. A. Heaman, A. Li, & S. McKellar (Eds.), Essays in Honour of Michael Bliss: Figuring the Social (pp. 273-303). University of Toronto Press. https://doi.org/10.3138/9781442688025-015
dc.relation.referencesRutty, C. J. (2020). A History of Connaught Laboratories. University of Toronto. Retrieved 31/01/2020 from http://connaught.research.utoronto.ca/history/
dc.relation.referencesS.V.S. (1988). Temes i notícies d’actualitat: 125 aniversario de la fundacion de Hoechst AG. Revista de la Reial Acadèmia de Medicina de Barcelona, 3(3), 181-182. https://raco.cat/index.php/RevistaRAMB/article/view/70928/90998
dc.relation.referencesSaleem, F., Hasaali, M. A., & Haq, N. u. (2016). Sci-Hub & ethical issues. Research in Social and Administrative Pharmacy, 13(1), 253-253. https://doi.org/10.1016/j.sapharm.2016.09.001
dc.relation.referencesSan José Montano, B. (2009). Acceso abierto (open access), un modelo necesario de comunicación científica. Revista Pediatría de Atención Primaria, 11(42), 299-311. http://scielo.isciii.es/pdf/pap/v11n42/11_colaboraciones.pdf
dc.relation.referencesSánchez-Serrano, I. (2011). 3 - A Brief Commercial History of the Biopharmaceutical Industry up to the Year 2000. In The World's Health Care Crisis: From the Laboratory Bench to the Patient's Bedside (1 ed., pp. 47-70). Elsevier Inc. https://doi.org/10.1016/B978-0-12-391875-8.00003-2
dc.relation.referencesSanofi-Pasteur. (2019). The Legacy Project. https://www.thelegacyproject.ca/#/timeline
dc.relation.referencesSanofi Canada. (2020). Our Toronto site boats a proud legacy of innovations in public health. https://www.sanofi.ca/en/about-us/sanofi-pasteur
dc.relation.referencesScheuerlein, H., Henschke, F., & Köckerling, F. (2017). Wilhelm von Waldeyer-Hartz-A Great Forefather: His Contributions to Anatomy with Particular Attention to "His" Fascia. Frontiers in surgery, 4, 74-74. https://doi.org/10.3389/fsurg.2017.00074
dc.relation.referencesSchlienger, J. L., & Blicklé, J. F. (2014). Les 20 ans qui suivirent la découverte de l’insuline [The 20-years following the discovery of insulin] [Article]. Médecine des Maladies Métaboliques, 8(6), 662-668. https://doi.org/10.1016/S1957-2557(14)70904-6
dc.relation.referencesSchwartz, R. S. (2004). Paul Ehrlich's Magic Bullets [Review]. New England Journal of Medicine, 350(11), 1079-1080. https://doi.org/10.1056/NEJMp048021
dc.relation.referencesSci-Hub. (2020a). About Sci-Hub. Retrieved 12 de septiembre de 2020 from https://sci-hub.ren
dc.relation.referencesSci-Hub. (2020b). Sci-Hub Ideas. Retrieved 10 de agosto de 2020 from https://sci-hub.ren
dc.relation.referencesSell, S. K., & Williams, O. D. (2020). Health under capitalism: a global political economy of structural pathogenesis [Journal Article]. Review of International Political Economy, 27(1), 1-25. https://doi.org/10.1080/09692290.2019.1659842
dc.relation.referencesSemba, R. D. (2012). The discovery of the vitamins [Internationale Zeitschrift fur Vitamin und Ernahrungsforschung / Journal International de Vitaminologie et de Nutrition] [Journal Article]. International Journal for Vitamin and Nutrition Research, 82(5), 310-315. https://doi.org/10.1024/0300-9831/a000124
dc.relation.referencesSen, S., Chakraborty, R., & De, B. (2016). “Diabesity”: Current Situation. In Diabetes Mellitus in 21st Century (pp. 45-53). Springer. https://doi.org/10.1007/978-981-10-1542-7_6
dc.relation.referencesSims, E. A. H., Danforth, E., Horton, E. S., Bray, G. A., Glennon, J. A., & Salans, L. B. (1973). Endocrine and Metabolic Effects of Experimental Obesity in Man. Recent Progress in Hormone Research, 29, 457-496. https://doi.org/10.1016/B978-0-12-571129-6.50016-6
dc.relation.referencesSinger, M., Bulled, N., Ostrach, B., & Mendenhall, E. (2017). Syndemics and the biosocial conception of health [Journal Article]. The Lancet, 389(10072), 941-950. https://doi.org/10.1016/s0140-6736(17)30003-x
dc.relation.referencesSoto, M. J. (2016). El sistema de publicaciones académicas: la historia de un sinsentido. Fundación Karisma. Retrieved 12 de septiembre de 2020 from https://web.karisma.org.co/el-sistema-de-publicaciones-academicas-la-historia-de-un-sinsentido/
dc.relation.referencesSPARC Europe. (2020). Open Access benefits. https://sparceurope.org/what-we-do/open-access/oa-benefits/
dc.relation.referencesStahnisch, F. W., & Verhoef, M. (2012). The Flexner Report of 1910 and its impact on complementary and alternative medicine and psychiatry in North America in the 20th century [Journal Article]. eCAM, 2012(Article ID 647896), 1-10. https://doi.org/10.1155/2012/647896
dc.relation.referencesStylianou, C., & Kelnar, C. (2009). The introduction of successful treatment of diabetes mellitus with insulin. Journal of the Royal Society of Medicine, 102(7), 298-303. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2711201/pdf/298.pdf
dc.relation.referencesSuárez D., J. C. (2015). ¿En qué consiste el “open access” o acceso abierto de contenidos? [Journal Article]. Revista La Propiedad Inmaterial(20), 119-134. https://doi.org/10.18601/16571959.n20.06
dc.relation.referencesSuber, P. (2006). Una introducción al acceso abierto (F. Enghel, Trans.). In D. Babini & J. Fraga (Eds.), Edición electrónica, bibliotecas virtuales y portales para las cienciassociales en América Latina y El Caribe (pp. 15-33). CLACSO, Consejo Latinoamericanode Ciencias Sociales. http://biblioteca.clacso.edu.ar/ar/libros/secret/babini/Peter%20Suber.pdf
dc.relation.referencesSuber, P. (2015). Acceso Abierto (R. Melero, Trans.) [book]. Universidad Autónoma del Estado de México. http://biblioteca.clacso.edu.ar/clacso/otros/20150820022027/PeterSuber.pdf
dc.relation.referencesSuber, P., & Pinto, A. (2012). Panorama sobre el Acceso Abierto (AA) (con especial atención al acceso abierto a artículos revisados por pares y sus pre-prints). Retrieved 13/09/2020 from http://legacy.earlham.edu/~peters/fos/overview-spanish.pdf
dc.relation.referencesSunder Rajan, K. (2006). Biocapital : The Constitution of Postgenomic Life [Book]. Duke University Press Books. https://doi.org/10.1215/9780822388005
dc.relation.referencesSwain, K. (2018). 'Extraordinarily arduous and fraught with danger': syphilis, Salvarsan, and general paresis of the insane [Journal Article]. The Lancet Psychiatry, 5(9), 702-703. https://doi.org/10.1016/S2215-0366(18)30221-9
dc.relation.referencesSwann, J. P. (1986). Insulin: A Case Study in the Emergence Of Collaborative Pharmacomedical Research. Pharmacy in History, 28(1), 3-13. https://login.ezproxy.unal.edu.co/login?url=https://www.jstor.org/stable/41110182
dc.relation.referencesSwartz, A. (2008). Guerilla Open Access Manifesto. Retrieved 13 de junio de 2020 from https://openaccessmanifesto.wordpress.com/manifiesto-de-la-guerrilla-por-el-acceso-abierto/
dc.relation.referencesSwinburn, B. A., Kraak, V. I., Allender, S., Atkins, V. J., Baker, P. I., Bogard, J. R., Brinsden, H., Calvillo, A., De Schutter, O., Devarajan, R., Ezzati, M., Friel, S., Goenka, S., Hammond, R. A., Hastings, G., Hawkes, C., Herrero, M., Hovmand, P. S., Howden, M., Jaacks, L. M., Kapetanaki, A. B., Kasman, M., Kuhnlein, H. V., Kumanyika, S. K., Larijani, B., Lobstein, T., Long, M. W., Matsudo, V. K. R., Mills, S. D. H., Morgan, G., Morshed, A., Nece, P. M., Pan, A., Patterson, D. W., Sacks, G., Shekar, M., Simmons, G. L., Smit, W., Tootee, A., Vandevijvere, S., Waterlander, W. E., Wolfenden, L., & Dietz, W. H. (2019). The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report. The Lancet, 393(10173), 791-846. https://doi.org/10.1016/S0140-6736(18)32822-8
dc.relation.referencesTan, S. Y., & Ponstein, N. (2019). Jonas Salk (1914-1995): A vaccine against polio. Singapore Medical Journal, 60(1), 9-10. https://doi.org/10.11622/smedj.2019002
dc.relation.referencesTattersall, R. (1995). A force of magical activity: the introduction of insulin treatment in Britain 1922-1926. Diabetic Medicine(12), 739-755. https://doi.org/10.1111/j.1464-5491.1995.tb02076.x
dc.relation.referencesTattersall, R. (2009). Diabetes: The Biography [Book]. OUP Oxford.
dc.relation.referencesThe Economist Intelligence Unit N.A. (2006). The birth of philanthrocapitalism. The Economist,, 378(8466), 9. http://ezproxy.unal.edu.co/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=edscpi&AN=edscpi.A142441943&lang=es&site=eds-live
dc.relation.referencesThe Nobel Foundation. (2020). The Nobel Prize in Physiology or Medicine 1962. https://www.nobelprize.org/prizes/medicine/1962/summary/
dc.relation.referencesThe Rockefeller University Hospital. (2010). Prelude to the Discovery of Insulin: Proving that a Pancreatic Substance Lowers Blood Sugar in Diabetes. The Rockefeller University. Retrieved 16/11/2019 from http://centennial.rucares.org/index.php?page=Pancreatic_Substance_Lowers_Bloo
dc.relation.referencesThompson, C. (2013). Hacktivism: Civil Disobedience or Cyber Crime? Pro Publica, 3. https://www.propublica.org/article/hacktivism-civil-disobedience-or-cyber-crime
dc.relation.referencesTobar, F. (2010). La enfermedad como catástrofe. Revista iSalud, 5(22), 60-62. https://www.paho.org/hq/dmdocuments/2010/enfermedadcomocatastrofe.pdf
dc.relation.referencesTransparency Market Research. (2014). Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,. Retrieved 07/06/2015 from http://www.transparencymarketresearch.com/biological-drugs-market.html
dc.relation.referencesTrujillo González, L. M. (2018). El financiamiento por parte de la industria farmacéutica a las organizaciones de pacientes con enfermedades raras: Un uso de la acción de tutela para inducir la demanda de ciertos medicamentos [Magister Research, Universidad Nacional de Colombia]. Bogotá D.C. https://repositorio.unal.edu.co/bitstream/handle/unal/63996/1032451358-2018.pdf?sequence=1&isAllowed=y
dc.relation.referencesUgalde, A., & Homedes, N. (2009). Medicamentos para lucrar. La transformación de la industria farmacéutica [Pills for profits. The transformation of the pharmaceutical industry]. Salud Colectiva, 5(3), 305-322. http://www.redalyc.org/articulo.oa?id=73111844002 (IN FILE)
dc.relation.referencesUNESCO. (2020). ¿Qué es acceso abierto? https://es.unesco.org/open-access/%C2%BFqu%C3%A9-es-acceso-abierto
dc.relation.referencesUniversity of Toronto. (2017). Biography of Sir Frederick Grant Banting (1891-1941). University of Toronto. Retrieved 23 de noviembre de 2019 from https://insulin.library.utoronto.ca/about/banting
dc.relation.referencesUniversity of Toronto. (2020). Sanofi Pasteur Limited (formerly Connaught). Retrieved 17/01/2020 from https://insulin.library.utoronto.ca/islandora/object/insulin%3Aconnaught
dc.relation.referencesUS Food and Drug Administration. (2015). FDA Drug Shortages. Retrieved 26/09/2015 from http://www.accessdata.fda.gov/scripts/drugshortages/default.cfm
dc.relation.referencesVaca González, C. P., Arteaga, L., & Delgado López, N. E. (2019). Magistral drug production in Colombia and other middle-income countries. Nature Biotechnology, 37(3), 216-217. https://doi.org/10.1038/s41587-019-0044-z
dc.relation.referencesValls Llobet, C., Banqué, M., Fuentes, M., & Ojuel i Solsona, J. (2008). Morbilidad diferencial entre mujeres y hombres [Differences in morbidity rates between men and women] [Journal Article]. Anuario de Psicología, 39(1), 9-22. https://www.raco.cat/index.php/AnuarioPsicologia/article/view/98015/159758
dc.relation.referencesVallverdú, J. (2007). ¿Por qué motivos crearemos máquinas emocionales? [Journal Article]. Astrolabio(5), 44-52. https://raco.cat/index.php/Astrolabio/article/view/197635
dc.relation.referencesVan Noorden, R. (2016). Nature's 10: Ten People Who Mattered This Year [Journal Article]. Nature, 540(7634), 507-515. https://doi.org/10.1038/540507a
dc.relation.referencesVargas Arbeláez, E. J. (2014). La política editorial de acceso abierto: horizontes de la democratización del conocimiento para el desarrollo [text]. Equidad y Desarrollo(21), 145-161. https://dialnet.unirioja.es/servlet/articulo?codigo=5166474
dc.relation.referencesVargas Beal, X. (2011). ¿Cómo hacer investigación cualitativa? Una guía práctica para saber qué es la investigación en general y cómo hacerla, con énfasis en las etapas de la investigación cualitativa (Apropiada para quien hace investigación por primera vez). ETXETA. http://www.paginaspersonales.unam.mx/files/981/94805617-Xavier-Vargas-B-COMO-HACER-INVESTIGA.pdf
dc.relation.referencesVayena, E., & Tasioulas, J. (2015). 'We the Scientists': a Human Right to Citizen Science. Philosophy & Technology, 28(3), 479–485. https://doi.org/10.1007/s13347-015-0204-0
dc.relation.referencesVelásquez Arango, G. (2015). Alternativas al modelo de investigación y desarrollo de medicamentos [Alternatives to the drug research and development model]. Salud Colectiva, 11(1), 23-34. https://www.scielosp.org/pdf/scol/2015.v11n1/23-34/es
dc.relation.referencesVenter, C., & Cohen, D. (2004). The Century of Biology. New Perspectives Quarterly, 21(4), 73-77. https://doi.org/10.1111/j.1540-5842.2004.00701.x
dc.relation.referencesVercellone, C. (2004). The hypothesis of cognitive capitalism London, United Kingdom. https://hal-paris1.archives-ouvertes.fr/file/index/docid/273641/filename/The_hypothesis_of_Cognitive_Capitalismhall.pdf
dc.relation.referencesVercellone, C. (2007). From Formal Subsumption to General Intellect: Elements for a Marxist Reading of the Thesis of Cognitive Capitalism [Article]. Historical Materialism(15), 13-36. https://doi.org/10.1163/156920607X171681
dc.relation.referencesVercellone, C. (2008). La thèse du capitalisme cognitif : une mise en perspective historique et théorique. In B. P. Gabriel Colletis (Ed.), Les nouveaux horizons du capitalisme. Pouvoir, valeur, temps (pp. 71-95). Economica. https://halshs.archives-ouvertes.fr/halshs-00401880
dc.relation.referencesVercellone, C. (2016). Capitalismo cognitivo y economía del conocimiento. Una perspectiva histórica y teórica. In F. Sierra Caballero & F. Maniglio (Eds.), Capitalismo financiero y comunicación (1 ed., pp. 17-49). Ediciones Ciespal.
dc.relation.referencesVercellone, C., & Cardoso, P. (2016). Nueva división internacional del trabajo, capitalismo cognitivo y desarrollo en América Latina [New international division of labor, cognitive capitalism and development in Latin America / A nova divisão internacional do trabalho, capitalismo cognitivo e desenvolvimento na América Latina] [Article]. Chasqui Revista Latinoamericana de Comunicación(133), 37-59. https://doi.org/10.16921/chasqui.v0i133.2941.g2821
dc.relation.referencesVerma, A. S., Agrahari, S., Rastogi, S., & Singh, A. (2011). Biotechnology in the realm of history [article in journal/newspaper]. Journal of Pharmacy and Bioallied Sciences, 3(3), 321-323. https://doi.org/10.4103/0975-7406.84430
dc.relation.referencesVillela Cortés, F., & Linares Salgado, J. E. (2011). Eugenesia: Un análisis histórico y una posible propuesta [Eugenics. A historical analysis and a possible proposal / Eugenia. Uma análise histórica e uma possível proposta]. Acta Bioethica, 17(2), 189-197. https://doi.org/10.4067/S1726-569X2011000200005
dc.relation.referencesWagner, C. (2016). Rosalind’s Ghost: Biology, Collaboration, and the Female [Article]. PLoS Biology, 14(11), 1-5. https://doi.org/10.1371/journal.pbio.2001003
dc.relation.referencesWaldeyer, W. (1888). Ueber Karyokinese und ihre Beziehungen zu den Befruchtungsvorgängen. Archiv für mikroskopische Anatomie, 32(1), 1-122. https://doi.org/10.1007/BF02956988
dc.relation.referencesWatson, D. (2019). Fordism: a review essay [Journal Article]. Labor History, 60(2), 144-159. https://doi.org/10.1080/0023656X.2019.1537031
dc.relation.referencesWatson, J. D., & Crick, F. H. C. (1953). Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid. Nature, 171(4356), 737-738. https://doi.org/10.1038/171737a0
dc.relation.referencesWeiner, C. (1987). Patenting and Academic Research: Historical Case Studies [Journal Article]. Science, Technology, & Human Values, 12(1), 50-62. https://doi.org/10.1177/016224398701200105
dc.relation.referencesWHO. (2018). WHO Report on Surveillance of Antibiotic Consumption 2016 - 2018 Early implementation. WHO. https://apps.who.int/iris/bitstream/handle/10665/277359/9789241514880-eng.pdf
dc.relation.referencesWHO. (2019a). Global Spending on Health: A World in Transition 2019 (Global Report, Issue. https://apps.who.int/iris/bitstream/handle/10665/330357/WHO-HIS-HGF-HF-WorkingPaper-19.4-eng.pdf
dc.relation.referencesWHO. (2019b). WHO Model List of Essential Medicines, 21st List (2019) https://apps.who.int/iris/bitstream/handle/10665/325771/WHO-MVP-EMP-IAU-2019.06-eng.pdf
dc.relation.referencesWHO. (2021). ATC/DDD Index 2021. WHO Colaborating Centre for Drug Statistics Methodology. Retrieved 07 de junio de 2021 from https://www.whocc.no/atc_ddd_index/
dc.relation.referencesWilliams, M., & Blacker, J. G. C. (2011). Pharmaceutical Process Development : Current Chemical and Engineering Challenges [Book]. Royal Society of Chemistry. https://doi.org/10.1039/9781849733076
dc.relation.referencesWilliams, R., Karuranga, S., Malanda, B., Saeedi, P., Basit, A., Besançon, S., Bommer, C., Esteghamati, A., Ogurtsova, K., Zhang, P., & Colagiuri, S. (2020). Global and regional estimates and projections of diabetes-related health expenditure: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Research And Clinical Practice, 162(108072), 1-10. https://doi.org/10.1016/j.diabres.2020.108072
dc.relation.referencesWilliamson, T. (2000). Understanding Enclosure. Landscapes, 1(1), 56-79. https://doi.org/10.1179/lan.2000.1.1.56
dc.relation.referencesWinston, E. (2017). The History of Ernst & Young. Retrieved 15 de septiembre de 2020 from https://classroom.synonym.com/the-history-of-ernst-young-12079682.html
dc.relation.referencesYildirim, R. V. (2013). Studies on de Materia medica of dioscorides in the Islamic era [Article]. Asclepio, 65(1). https://doi.org/10.3989/asclepio.2013.07
dc.relation.referencesZerda, Á., Velásquez, G., Tobar, F., & Vargas, J. E. (2001). Sistemas de seguros de salud y acceso a medicamentos - Estudios de casos de Argentina, Colombia, Costa Rica, Chile, Estados Unidos de América y Guatemala (OMS, Ed.). OMS. http://digicollection.org/hss/en/d/Jh2958s/
dc.relation.referencesZhang, Y.-H. P., Sun, J., & Ma, Y. (2017). Biomanufacturing: history and perspective. Journal Of Industrial Microbiology & Biotechnology, 44(4-5), 773-784. https://doi.org/10.1007/s10295-016-1863-2
dc.relation.referencesZukerfeld, M. (2006). Bienes Informacionales y Capitalismo Cognitivo: Conocimiento, información y acceso en el siglo XXI. Revista Electrónica Razón y Palabra, Diciembre 2006 - Enero 2007(54). http://www.razonypalabra.org.mx/anteriores/n54/mzukerfeld.html
dc.relation.referencesZukerfeld, M. (2008a). El rol de la propiedad intelectual en la transición hacia el capitalismo cognitivo. Argumentos Revista de crítica social(9), 1-25. https://publicaciones.sociales.uba.ar/index.php/argumentos/article/view/862
dc.relation.referencesZukerfeld, M. (2008b). Propiedad Intelectual y Capitalismo Cognitivo: Breve historia de un matrimonio forzoso. XXI Jornadas de Historia Económica, 25. Retrieved septiembre 23–26, from http://xxijhe.fahce.unlp.edu.ar/programa/descargables/zukerfeld.pdf
dc.relation.referencesZukerfeld, M. (2010a). La reciente expansión de la propiedad intelectual: una visión de conjunto. In El papel de las ciencias sociales en la construcción de la sociedad del conocimiento. Aportaciones de los participantes al Summer School del proyecto EULAKS (pp. 60-90). FLACSO México. https://e-tcs.org/wp-content/uploads/2017/03/Zukerfeld-2010-La-expansi%C3%B3n-de-la-Propiedad-Intelectual-una-explicaci%C3%B3n-de-conjunto.pdf
dc.relation.referencesZukerfeld, M. (2017a). Knowledge in the Age of Digital Capitalism: An Introduction to Cognitive Materialism (S. Wylie, Trans.) [eBook]. University of Westminster Press. https://doi.org/10.16997/book3
dc.relation.referencesZukerfeld, M. (2010b). Volumen III - Las regulaciones del Acceso a los conocimientos en el Capitalismo Informacional: Propiedad Intelectual y más allá Universidad de Buenos Aires]. Buenos Aires, Argentina. https://capitalismoyconocimiento.wordpress.com/trilogia-capitalismo-y-conocimiento/volumen-iii/
dc.relation.referencesZukerfeld, M. (2017a). Knowledge in the Age of Digital Capitalism: An Introduction to Cognitive Materialism (S. Wylie, Trans.) [eBook]. University of Westminster Press. https://doi.org/10.16997/book3
dc.relation.referencesZukerfeld, M. (2017b). The tale of the snake and the elephant: Intellectual property expansion under informational capitalism [Article]. Information Society, 33(5), 243-260. https://doi.org/10.1080/01972243.2017.1354107
dc.relation.referencesZukerfeld, M. (2017b). The tale of the snake and the elephant: Intellectual property expansion under informational capitalism [Article]. Information Society, 33(5), 243-260. https://doi.org/10.1080/01972243.2017.1354107
dc.relation.referencesZukerfeld, M. (2017c). Typologies of knowledge: a reexamination from the perspective of cognitive materialism. Prometheus - Critical Studies in Innovation, 1-18. https://doi.org/10.1080/08109028.2017.1357259
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.subject.decsHealth services
dc.subject.decsServicios de salud
dc.subject.decsBasic health services
dc.subject.decsServicios básicos de salud
dc.subject.lembCapitalism
dc.subject.lembCapitalismo
dc.subject.proposalCapitalismo cognitivo
dc.subject.proposalCognitive capitalism
dc.subject.proposalMedicamentos biotecnológicos
dc.subject.proposalPropiedad intelectual
dc.subject.proposalInsulina
dc.subject.proposalDiabetes mellitus
dc.subject.proposalDeterminación social
dc.subject.proposalEquidad en salud
dc.subject.proposalBiotechnological medicines
dc.subject.proposalIntellectual property
dc.subject.proposalInsulin
dc.subject.proposalDiabetes mellitus
dc.subject.proposalSocial determination
dc.subject.proposalEquity in health
dc.title.translatedSocial determination of inequality in access to biotechnological medicines in cognitive capitalism: the case of recombinant insulin in Colombia
dc.type.coarhttp://purl.org/coar/resource_type/c_db06
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aa
dc.type.contentText
dc.type.redcolhttp://purl.org/redcol/resource_type/TD
oaire.accessrightshttp://purl.org/coar/access_right/c_abf2
oaire.fundernameColciencias (Minciencias)
dcterms.audience.professionaldevelopmentEstudiantes
dcterms.audience.professionaldevelopmentInvestigadores
dcterms.audience.professionaldevelopmentPúblico general
dcterms.audience.professionaldevelopmentResponsables políticos


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-SinDerivadas 4.0 InternacionalThis work is licensed under a Creative Commons Reconocimiento-NoComercial 4.0.This document has been deposited by the author (s) under the following certificate of deposit